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An ancient and ubiquitous set of enzymes known as the aminoacyl-tRNA synthetases are
required for the viability of all organisms. The aminoacyl-tRNA synthetases catalyze the
attachment of amino acids onto tRNA molecules. The aminoacylated, or charged, tRNA is then
transported and utilized at the ribosome for the synthesis of proteins. The genome of the
hyperthermophilic microorganism Sulfolobus islandicus (S. islandicus) harbors a unique leucyltRNA synthetase paralog, LeuRS-I, of unknown function. While its duplicate, LeuRS-F, carries
out all the classical functions of LeuRS-family enzymes, LeuRS-I fails to charge leucine onto
tRNALeu, despite its ability to activate this amino acid and bind this tRNA substrate. To begin to
understand the molecular function of this unusual LeuRS within S. islandicus, new approaches of
inquiry are needed. A variety of biotechnological methods were developed in an attempt to piece
together the activity of this paralogous synthetase and understand the role it plays within S.
islandicus.
KEYWORDS: Archaea, Sulfolobus, aminoacyl-tRNA synthetase (aaRS), LeuRS, paralogs,
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CHAPTER I: INTRODUCTION
The aminoacyl-tRNA synthetases – an overview
The aminoacyl-tRNA synthetases (aaRS) are essential enzymes found within all kingdoms
of life. These ancient enzymes bridge the worlds of nucleic acids and proteins by catalyzing the
addition of an amino acid to their cognate transfer RNA (tRNA) molecule in a two-step reaction.[1]
The reaction first begins with the activation of an amino acid via adenosine triphosphate (ATP),
forming an adenylated amino acid intermediate with the subsequent release of the byproduct
pyrophosphate.[1] Next, the tRNA synthetase catalyzes the formation of an ester linkage between
a tRNA and the carboxyl moiety of the activated amino acid, the process of which is commonly
referred to as aminoacylation or charging.[2] This linkage forms a stable tRNA – amino acid
product (aa-tRNA) that will be used in the synthesis of proteins at the ribosome.[1,2] Secondary
carrier elongation molecules within bacteria known as EF1-A and EF1-B perform the task of
transporting the newly synthesized aa-tRNA molecule to the ribosome where it will be decoded
and used to form stable polypeptide fragments.[3,4] The aminoacyl-tRNA synthetases are broken
into two major classes: class I aminoacyl-tRNA synthetases and class II aminoacyl-tRNA
synthetases.[5] The major subdivision of these classes of enzyme is defined by both the domain
structures of the tRNA binding fold and, accordingly, how the amino acid becomes attached to the
tRNA’s acceptor stem, with type I aminoacyl-tRNA synthetases possessing a characteristically
monomeric Rossman fold binding domain and type II aminoacyl-tRNA synthetases exhibiting
multimeric anti-parallel beta-sheets flanked by alternative domains.[5] The aminoacyl-tRNA
synthetases have been used to understand the evolutionary similarities and dissimilarities of
organisms across the three domains of life. Analysis of the aminoacyl tRNA synthetases has been
utilized in tandem with previous work performed by Iwabe and colleagues and, subsequently,
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Brown and Doolittle whom provided strong evidence of close sequence comparation between
archaebacteria and eukaryotes, ultimately delineating a general evolutionary affiliation amongst
the three domains of life.[6,7]
Sulfolobus islandicus, a model hyperthermophilic organism
The single-celled archaeon Sulfolobus islandicus, of the family Sulfolobaceae and phylum
Crenarchaeota, is an extremophilic organism. S. islandicus was initially isolated from areas around
the Solfatara volcano in Italy by Brock and cohort.[8] This organism is characterized by its ability
to oxidize sulfur, to survive through both heterotrophic and chemolithoautotrophic means, and its
adapted persistence to harsh conditions, surviving in a habitable temperature range of 65 to 85°C
and a pH range of 2 – 4.[8] The shape of S. islandicus cells are lobed spheres that range in size
between 0.8-1.0 µm, typically exhibiting little size variation.[8] Today, many geographically
isolated and unique strains of S. islandicus have been found in geologically active areas including
volcanic vents present in Yellowstone National Park, Iceland, Russia and South America, amongst
others.[9] Sulfolobus species have provided a strong platform for understanding archaeal
phylogenetics within the crenarchaeal system, in elucidating cellular machinery such as
transcription apparatuses and stress-response systems, and have even been used to study cell cycle
regulation due to their genetic tractability and ease of culturing in a laboratory setting. [10] More
specifically, S. islandicus has been the topic of extensive research in the field of virus-host
relationships, DNA replication and repair, biogeographical analyses of pan-genomes within the
species, and has been utilized to tailor advanced genetic toolboxes for easy and extensive
manipulation within the laboratory setting.[11,12,13,14]
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Duplication of aaRSs’ and the act of mistranslation
With the publication of S. islandicus’ genome nearly 30 years after the discovery of the
organism, unique genes were identified and examined in a paper published by Weitzel and
colleagues.[15] Strikingly, S. islandicus was found to possess a conserved duplicated copy of a nonessential leucyl-tRNA synthetase (LeuRS, denoted as LeuRS-I for infidelity) seemingly incapable
of performing the standard activity of charging along with the canonical copy of the LeuRS
(denoted as LeuRS-F for fidelity) that is essential in performing the charging of leucine onto
tRNALeu, therefore making this protein tantamount to the survival of the cell.[15] The function of
LeuRS-I has yet to be determined, while LeuRS-F exhibits canonical aminoacyl-tRNA synthetase
activity. LeuRS-I is deemed as having “infidelity” due to a suspected editing deficiency found in
the CP1 editing domain (connective polypeptide) of this class I aminoacyl-tRNA synthetases based
upon signature sequence analysis, though it has been shown to both activate leucine and bind to
tRNALeu.[15] The function of LeuRS-I has yet to be determined, while LeuRS-F exhibits canonical
aminoacyl-tRNA synthetase activity. The CP1 domain of LeuRS-I lacks the universal aspartic acid
that is critical in eliciting the hydrolytic activity required for editing mischarged tRNA, while
LeuRS-F possesses the canonical hydrolytic aspartic acid in its CP1 domain.[15,16] Editing can
occur via two separate mechanisms: pre-transfer and post-transfer editing. Pre-transfer editing
occurs when an aminoacyl adenylate (aa-AMP) is formed by the addition of an improper amino
acid which is subsequently hydrolyzed in the aminoacylation active site of an aaRS using currently
undefined amino acids. This activity within the aminoacylation active site causes the release of the
amino acid, thereby allowing the process to start anew. A secondary mechanism known as posttransfer editing resolves the improper mischarging of tRNA with a non-cognate amino acid via a
discrete editing site on the aminoacyl-tRNA synthetase.[17] A double-sieve model first proposed
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by Fresht and Ketner postulated the presence of both a “coarse” sieve or active site that
discriminates against amino acids that are too large and thereby incompatible with the given
aminoacyl-tRNA synthetase and a “fine” sieve that eliminates mischarged amino acids via editing
mechanisms within editing active sites on the enzyme.[18] Though it is unclear as to the utility of
LeuRS-I and its non-functional editing domain, proof exists that such a mutation of the hydrolytic
aspartic acid to alanine within the CP1 domain of E. coli LeuRS rendered the enzyme incapable
of post-transfer editing.[19] The implications of such inactivity within S. islandicus LeuRS-I editing
suggests a capacity for mischarging at elevated rates and potentially increasing mistranslation of
proteins downstream.
Extensive research has been conducted in a host of organisms aiming to understand
mistranslation, which represents itself as both a boon and a detriment depending on the organismal
system in question and the specific types of amino acid substitution during protein synthesis. A
possibility exists in which LeuRS-I purposefully attaches non-cognate amino acids on to tRNALeu
or other tRNA isoforms present within the cell under a specific set of required conditions, leading
to the incorporation of these improper amino acids into a polypeptide chain. While mistranslation
is generalized and at basal levels within many different organisms, the elicitation of heightened
levels of mistranslation is often caused by an increase in the stress response of the cell by abiotic
or biotic stressors.[20]
Degenerate aminoacyl-tRNA synthetases that lack many of the important editing
mechanisms of standard aaRS’ can be found in a host of different prokaryotic and archael
organisms. One such organism, Mycoplasma mobile, possesses degenerated aminoacyl-tRNA
synthetases such as LeuRS which is completely devoid of the CP1 editing domain and thus, is
incapable of the pre or post transfer editing of improperly charged tRNA’s which then go on to
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incorporate translational errors at the ribosome. This leads to possessing “statistical proteomics”,
meaning these organisms accumulate a reservoir of uniquely substituted proteins that potentially
provide phenotypic plasticity and flexibility within the organism.[21] A separate example exists
within mammalian cells in the case of methionyl-tRNA synthetase (MetRS). MetRS is capable of
attaching methionine to non-cognate tRNA’s and can be induced with oxidative stress to perform
this mismethionylation at higher percentages, from basal levels of mistranslation at 1% up to 10%
in cases of stress, with a proposition by the discovering authors of this mechanism as being
“adaptive mistranslation.”[22]
Speculation exists that the lack of editing capacity in certain aaRSs could be of benefit to
an organism under a suite of stressful conditions and has been demonstrated in a variety of bacterial
and archaeal species as reported by Ibba and colleague.[23] The hyperthermophilic organism
Aeropyrum pernix grows in a temperature range of 70 – 100°C.[24] When challenged with the
substandard temperature of 75°C, A. pernix constitutively mischarges methionine onto tRNALeu
via methionyl-tRNA synthetase.[24] Schwartz and colleague demonstrated that this mistranslation
surprisingly heightened the activity of methionine-substituted citrate synthase isolated from cells
grown at low temperatures relative to wild type enzyme recovered from cells grown under
appropriate conditions.[24] The investigators speculate that mistranslation increases the flexibility
and therefore the activity of certain proteins under chilling temperatures.[24] In a recent paper
published in PLOS Genetics, researchers found that basal and artificially induced global
mistranslation in Escherichia coli enhanced cell survival by increasing the activation of the SOS
response under DNA damage during UV radiation, hydrogen peroxide exposure and ciprofloxacin
treatments.[25] These findings further support the hypothesis that, while generalized mistranslation
under normal conditions can be detrimental to the survival of the cell, mistranslation in response
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to environmental challenge could provide benefits to the organism by altering the amino acid
composition of proteins, thereby altering function or capacity of function.[25] Indeed, what was
once believed to be a solely negative process within organisms has been scrutinized and opposed
given the wide range of experimental data running contrary to original paradigms. As such,
adaptive mistranslational mechanisms might be at work within S. islandicus and closely related
strains.
A criterion for organismal viability once posited that the presence of twenty aaRSs, one for
each of the standard amino acids in a cell, was a standard found in all life.[26] While this is the
typical case, examples exist that defy this standard; one such example is exhibited in the
prokaryotic species Anabaena sp. PCC 7120.[27] This organism possesses two unique copies of
threonyl-tRNA synthetase, one being predominantly active only during times of low zinc
availability.[27] This zinc-starvation induced copy contains a defunct editing domain N2 that
significantly impairs post-transfer editing activity and permits the mischarging of serine onto
tRNAThr.[27] Another example of a paralogous tRNA-synthetase exists in the prokaryotic biocontrol
species Agrobacterium radiobacter.[28] A. radiobacter produces the antibiotic agrocin 84 which
mimics a substrate derived from the plant tumor-inducing species Agrobacterium tumefaciens.[28]
Agrocin 84’s mechanism of action is through the inhibition of A. tumefaciens’ LeuRS, ultimately
halting translation in the organism.[28] A. radiobacter possesses two copies of LeuRS, one of which
is resistant to the activity of agrocin 84, thus preventing self-toxification.[11]
Interestingly, the duplication or horizontal transfer of aaRS genes is more frequent than
originally predicted and occurred in many prokaryotic and archaeal species. Speculation exists that
duplicated forms, while often non-essential, likely confer selective advantages to the host as
proposed in the archaeal lineage of the Halobacteriales.[29] The order Halobacteriales of the phylum

6

Euryarchaeota possess three unique LeuRS, the first of which was transmitted via an ancient
common ancestor of the bacterial domain which was subsequently duplicated or genetically
transferred within organisms of the haloarchaea leading to the three distinct forms seen today. The
function of the duplicate forms of LeuRS within these organisms is still unclear.[29] The aaRSs are
among the more frequent horizontally transferred genes amongst cells in an evolutionary
context.[30] As reported by Woese and colleagues, phylogenetic analyses of aaRSs present in a
plethora of organisms from the three domains of life revealed a strong pattern of horizontal gene
transfer over an ancient and extended timescale.[30]
Along with the occurrence of duplicated forms of aminoacyl-tRNA synthetases amongst a
wide range of organisms, modified forms of aminoacyl-tRNA synthetases such as tyrosyl-tRNA
synthetase (TyrRS) found in higher organisms possess additional domains that have no bearing on
the activity of aminoacylation while adding secondary activities that are important to the
organism.[31] TyrRS contains two unique domains, tripeptide ELR and EMAPII, which work in
tandem within receptor-mediated signaling pathways related to angiogenesis.[31] An example of
tryptophanyl-tRNA synthetase (TrpRS) in higher organisms exists by which an addition of a
WHEP domain to the synthetase acts as an inhibitor of the potent angiostatic activity of TrpRS
within the cell.[31] While no additional domains appear present on LeuRS-I, that does not disclude
the enzyme from having novel functionality outside of being a standard aminoacyl-tRNA
synthetase, the activity of which has yet to be determined experimentally. At the core of this
evolutionary black box, the elucidation of S. islandicus’ duplicate LeuRS system is of great
importance in determining its relevance and utility in the species.
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Duplication of LeuRS in Sulfolobus islandicus – potential ramifications
Through the comparison of sequence identity between the two copies of LeuRS present in
S. islandicus, it was shown that LeuRS-I shares nearly 40% amino acid sequence identity with that
of LeuRS-F. The C-terminal domains of LeuRS-F and LeuRS-I are even more dissimilar as
compared to alignments of the full proteins, approaching only 20% identity (Figure 1). Some of
these variances in sequence are seemingly significant and reside in important areas such as the
CP1 domain, perhaps shedding light on the activity of LeuRS-I given that it is capable of both
activating leucine and binding tRNALeu though it is incapable of charging tRNALeu.[15] If LeuRS-I
were capable of charging tRNALeu, it would more than likely be incapable of editing mischarged
tRNA leading to downstream mistranslation. This mistranslation leads to amino acids chemically
and structurally similar to leucine being substituted at leucine codons. It is possible that LeuRS-I
competes with LeuRS-F for substrate given that they have both been shown to be present in the
cytoplasm of the cell based upon preliminary ultra-centrifugation and fractionation experiments.
This activity between the two enzymes could possibly alter the dynamics of aminoacylation and
translation by acting as a resource detection switch that modulates the activity of the two enzymes
based upon the levels of aminoacylation resources within the cytoplasm. One such possibility
could be the functional relevance of LeuRS-I producing mischarged tRNA which is inherently
deacylated by LeuRS-F, the act of which is known as editing in-trans.[32] Under a certain set of
conditions, this activity of trans editing could potentially be elicited by LeuRS-F in the presence
of misacylated tRNALeu generated by LeuRS-I while a secondary condition leaves these
improperly charged tRNA’s unfettered. For instance, if LeuRS-I were capable of charging leucine
on to a non-cognate tRNA, LeuRS-F should be incapable of binding to this non-cognate tRNA and
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therefore be unable to edit in-trans, with the subsequent downstream effect of mistranslation
occurring.
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Figure 1: Comparison of leucyl-tRNA synthetases from E. coli, S. islandicus, and P.
horikoshii, along with C-terminal domain comparison. Synthetases aligned using Clustal Omega.
Summary of Research Objectives
Greatest divergence of sequence identity can be seen between the C-terminal domains of LeuRSF and LeuRS-I with consensus data shown.
Summary of research objectives
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Summary of research objectives
The elucidation of LeuRS-I’s function in S. islandicus is the utmost priority of our research
project. The production of molecular tools that can aid in the analysis or detection of LeuRS-I both
in vitro and in vivo will help us accomplish our goals of determining the presence and amount of
this paralog in S. islandicus throughout its growth phases during favorable and challenging
environmental conditions. These tools include generating polyclonal antibodies that are selective
in their recognition of LeuRS-I along with the production of an epitope-tagged genomic LeuRS-I
for downstream experimentation. Both of these developed tools would provide methods for
tracking in vivo expression levels of LeuRS-I, and speculatively, yield one of three outcomes: 1)
LeuRS-I is found to be constitutively expressed, 2) its presence in S. islandicus is temporally
controlled and is only expressed during certain stages of growth, or 3) LeuRS-I is only expressed
during unfavorable or stressful growth conditions. With the previous information in mind, a variety
of different conditions with which to utilize these tools can be employed as treatments to elicit
potential expression levels of this enzyme and detect its presence.
If the presence of S. islandicus’ LeuRS-I cannot be detected under standard growth
conditions, low temperatures that would be considered a harsh environmental challenge to the
organism could be employed to elicit its detection. Along these lines, changes in the pH of S.
islandicus’ media could also be adopted as a stressor in an attempt to detect LeuRS-I in vivo.
Following this rationale, an example of a similar scenario is observed in discrete temperaturedependent, pH inducible forms of lysyl tRNA-synthetase (LysRS) from E. coli K-12 MG1655.[33]
Two copies of a gene encoding for LysRS exist in the E. coli K-12 genome, denoted as lysS and
lysU, respectively.[33] The lysS gene is found to be constitutively active at standard conditions
while transcription of the lysU gene is induced at pH’s of 5.5 or lower, with temperatures below
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37°C affecting the induction of this gene negatively.[33] If the efficacy of LeuRS-I specific
antibodies and a C-terminal HA-tagged LeuRS-I can be verified, a variety of experimental
parameters can be employed in determining the presence and relative abundance of LeuRS-I in S.
islandicus cells.
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CHAPTER II: EXPERIMENTAL METHODS
tRNA Extractions
Methods for extracting tRNA from both Escherichia coli (E. coli) and S. islandicus were
developed in the Weitzel laboratory with the intention of obtaining reproducible and consistent
yields of tRNA for downstream applications. Several trials were conducted as described below.
Method I: Small-scale extraction of total S. islandicus tRNA
Wild type and leuRS-I knockout cultures were started from freezer stocks by inoculating 2
mL of DT/AU media consisting of 0.3% K2SO4, 0.05% NaH2PO4, 0.0145% MgSO4, 0.01%
CaCl2•2H2O, 0.1% Dextrin, 0.1% EZMix N-Z-Amine A, 20 µg/mL uracil, 20 µg/mL agmatine,
0.00006% FeCl3, 0.00001% CoCl2•6H2O, 0.00001% MnCl2•4H2O, 0.00001% ZnCl2, and
0.00001% CuCl2•2H2O (wt/vol) with 100 µL of semi-frozen stock. Drams were allowed to
incubate at 75°C for two days. Noting cloudiness, 1 mL of these starter cultures were then passaged
into 20 mL of fresh DT/AU (passage 1 cells) and allowed to grow at 75°C until an optical density
at 600 nm (OD600) of approximately 0.2 (~ three days). Both samples were then passaged a second
time into 100 mL of fresh DT/AU media, standardizing initial OD600s to 0.008. Samples were,
again, grown at 75°C until each reached OD600s of approximately 0.3. Cells were harvested via
centrifugation at 8,000 x g for 30 minutes at 4°C. Spent DT/AU medium was discarded and cell
pellets were placed on ice.
For the initial lysis, pellets were resuspended in 1 mL of LiCl reagent (2.5 M LiCl, 50 mM
Tris-HCl pH 8.0, 4% triton X-100, 62.5 mM EDTA pH 8.0). The LiCl salt is primarily used in
extractions that require the inclusion of small RNA’s due to their solubility in the reagent, while
large RNA is readily excluded due to their insolubility in this reagent.[34] An equal volume of acid
phenol:chloroform:isoamyl alcohol (Ambion, P:C:I 125:24:1), pH 4.5 was added to each cellular
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resuspension followed by vigorous vortexing to further homogenize. Samples were then incubated
on ice for 10 minutes.
After incubation, the lysates were transferred to 15 mL falcon tubes and centrifuged at
13,500 x g for 10 minutes at 4°C. After centrifugation, a visibly thick plug was present in each
sample, likely containing membrane and denatured protein, that occluded the aqueous layer from
migrating to the top of the extraction. To remedy this issue, 0.5 mL of each reagent (now currently
1.5 mL for the updated protocol), or 1:1 LiCl and P:C:I solution, was added to each, mixed
vigorously, and re-centrifuged to separate the layers. These additional steps resulted in wellresolved aqueous layers that were collected and transferred to fresh 15 mL falcon tubes. In an
effort to remove residual phenol, 1.6 mL pure chloroform was added to both samples and mixed
vigorously. Subsequently, samples were centrifuged at 13,500 x g for 10 minutes at 4°C,
afterwhich roughly 1.5 mL of a top aqueous phase was collected. This crude tRNA-containing
solution was transferred to a 15 mL conical tube.
To initiate precipitation of extracted RNAs, sodium acetate (NaOAc), pH 5.2 was added to
the crude tRNA to a final concentration of 0.3M prior to the addition of 2.5 volumes of -20°C
absolute ethanol. The samples were gently mixed and placed at -20°C overnight. After this
overnight incubation, samples contained tendrils of white precipitate. Precipitates were collected
via centrifugation at 13,500 x g for 10 minutes at 4°C. Resulting supernatants covering visible
pellets of nucleic acid and/or salt were discarded. Pellets were rinsed twice with 2 mL of 70%
ethanol, while also ensuring that the sides of the tube were rinsed to remove residual NaOAc or
LiCl. To ensure that the pellets were retained, between and after the final rinse, samples were
centrifuged at 13,500 x g for 10 minutes at 4°C. To remove residual ethanol, rinsed pellets were
allowed to dry in a laminar flow hood for 10 minutes. Pellets were resuspended in 15 µL Ambion
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elution buffer (AEB, 10 mM Tris pH 7.0, 0.1 mM EDTA). After the pellets were completely
dissolved, nucleic acid concentration (absorbance at 260 nm) and quality (260 nm/280 nm and 260
nm/230 nm ratios) were assessed using a Nanodrop One (Fisher Scientific) using the RNA
protocol.
To assess the quality of the crude tRNA extracts, the samples were analyzed via 12%
polyacrylamide sequencing gels. A 12% polyacrylamide, 7 M urea solution was made by mixing
solutions of 1x TBE/7M urea [89 mM Tris pH 7.6, 89 mM boric acid, 2 mM
ethylenediaminetetraacetic acid (EDTA)] and 20% acrylamide (19:1) in 1x TBE/7M urea. The
polymerization reaction was initiated with 10% ammonium persulfate (APS, 0.0064% vol/vol) and
tetramethyelthylenediamine (TEMED, 0.0019% vol/vol). Gel samples were prepared by adding
RNA loading buffer to a 1x final concentration [0.175 M Urea, 10 mM EDTA pH 8.0, 0.000025%
xylene cyanol (wt/vol) and 0.000025% bromophenol blue (wt/vol)] to 2000 ng of diluted crude
wild type and knockout tRNA. An in vitro transcribed Si tRNALeu-UAG isoacceptor (2000 ng)
generated within the lab was used as a control sample for comparison to endogenously extracted
total tRNA. Gels were run in 1x TBE at a constant current of 20 mA resulting in a steady voltage
of approximately 1250 V. If the voltage increased dramatically, the current was iteratively
decreased to reestablish the desired 1250 V. Gels were stopped when the xylene cyanol dye band
was 2 – 3 cm from the bottom.
The developed extraction protocol was applied to the isolation of total Escherichia coli
tRNA to assess its broader applicability. Five milliliters of Lysogeny broth (LB, 1% Typtone w/v,
1% NaCl w/v, 0.5% Yeast extract w/v) was placed into a glass culture tube and inoculated with 50
µL of E. coli BL21 freezer stock. The inoculated medium was incubated in an incubator-shaking
(incu-shaker) at 37°C and 200 rpm overnight. The next day, the culture tube contained noticeably
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thick growth. This starter culture was used to inoculate 30 mL of LB at an initial OD600 of 0.008
prior to incubating at 37 °C with aeration (200 rpm). The culture was monitored over the course
of 6 hours. Cells were harvested via centrifugation (15,000 x g, 15 min, 4°C) after reaching an
OD600 of 1.4. Total tRNA was extracted as previously described, though the requirement of
additional LiCl and P:C:I was unnecessary due to proper separation of the aqueous and organic
phases following centrifugation. The resulting tRNA pellet was allowed to dry in the laminar flow
hood for 10 minutes and was subsequently resuspended in 100 µL of AEB. The tRNA
concentration and quality were assessed using the NanoDrop One (Thermo Fisher) and its RNA
protocol.
Method II: Large-scale extraction of total S. islandicus tRNA
As assessed by PAGE, limited quantities of properly sized RNA were obtained using the
small-scale extraction protocol. Therefore, isolation of total Si tRNA was attempted on a large
scale. Passage 1 cells were allowed to grow in 20 mL of DT/AU media at 75°C to a final OD600 of
0.370 (three days). Four 2.5 L Fernbach flasks, each containing 250 mL of DT/AU media pH 3.5,
were inoculated with 4.5 mL of passage 1 cells to a starting O.D of 0.008. The inoculated flasks
were placed in the 75°C incubator and grown for 5 days. Optical densities at 600 nm were obtained
for each flask and measurements ranged from 0.191 to 0.317. Cells were harvested via
centrifugation at 4250 rpm (45 min at 4°C). Cell pellets were processed as described for Method
I extractions except using initial LiCl reagent and P:C:I volumes of 2 mL each. After
centrifugation, a thick cream-colored layer was present in the tube, again occluding the aqueous
layer from separating from the organic layer. An additional 1mL of LiCl was added to the tube,
followed by brief bouts of vigorous vortexing and additional centrifugation. As before, these
additional steps yielded a well-resolved aqueous layer. This crude total tRNA-containing fraction
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was collected, and the nucleic acids were precipitated using NaOAc/ethanol as previously
described. The resulting crude, total tRNA pellet was dried in the laminar flow hood for 15
minutes and resuspended in 50 µL of AEB. Sample was tested for concentration and purity via the
Nanodrop One and its RNA protocol.
A leuRS-I knockout strain has a characteristic lag-in-growth phenotype at sub-optimal
temperatures for S. islandicus. A reasonable interpretation is that LeuRS-I activity is more
important to S. islandicus under these stressful conditions. Additionally, LeuRS-I may need a
tRNA substrate containing a modification found only under these conditions. Therefore, to isolate
tRNAs that may contain such alterations, a second, large-scale total tRNA extraction of wild type
S. islandicus cells was performed with the following modifications. Passage 1 cells were processed
as described. At the optimal OD600 of 0.380, cells were harvested and diluted into two flasks, each
containing 500 mL of fresh DT/AU medium, at an initial OD600 of 0.008. Inoculated medium grew
at 60°C with aeration (230 rpm) until OD600 readings of approximately 0.340 and 0.470 (~ 6 days)
were obtained. Cells were harvested and total tRNA was extracted as described except each pellet
originating from 500 mL of culture was processed individually using 2.0 mL of LiCl and 2.0 mL
of P:C:I. Additionally, insoluble/solvent phases resulting from the initial extraction were back
extracted with 2 mL of additional LiCl to recoup additional RNA. Because of this 4 mL of
chloroform was used to remove residual phenol from the combined aqueous phases. RNA pellets
obtained after NaOAc/EtOH precipitations were resuspended in 50µL of AEB.
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Method III: Agarose bleach gel electrophoresis
Due to the laborious nature of pouring, running, and developing sequencing
polyacrylamide gels to observe tRNA quality, a secondary method of electrophoretic analysis was
implemented following the work of Aranda and colleagues.[35] 2% bleach gels were made by
adding 2 g of agarose LE (Goldbio) to 100 mL of 1x tris base, acetic acid and EDTA solution
(TAE, 40 mM Tris base, 20 mM Acetic acid, 1 mM EDTA). The agarose slurry was mixed
thoroughly and microwaved at 80% power for 1 minute, mixed again, and then microwaved in 30
second increments at 80% power until fully dissolved. To this, 1 mL of bleach (Clorox) was added
followed by brief microwaving at 80% power. Ethidium bromide was added to the solution at a
final concentration of 0.5 µg/mL followed by 20 seconds of microwaving at 80% power. tRNA
samples were diluted to 1 µg/µL. Dilutions were mixed 1:1 (vol:vol) with 2x NEB ssRNA loading
dye (47.5% formamide, 0.01% SDS, 0.01% bromophenol blue, 0.005% xylene cyanol, 0.5mM
EDTA). 2 µg of RNA samples were loaded unless otherwise indicated. Low-range ssRNA ladder
(NEB) was prepared for electrophoresis by adding 2 µL of low-range ssRNA ladder to 2 µL of 2x
loading dye. Agarose bleach gels were run for 30 minutes at a constant voltage that equated to 90
mA, starting from 100 V and ending at 87 V. Typically, voltage was attenuated twice to ensure 90
mA were maintained. The gel was assessed on a UVP GelDoc-It system.
Method IV: Small RNA enrichment
Bleach gels routinely revealed the presence of larger nucleic acid contaminants within
extraction solutions. These larger nucleic acid species were assumed to be primarily genomic DNA
(gDNA), ribosomal RNA, and larger mRNA species. To remove larger RNA species, an additional
precipitation with LiCl reagent was utilized. Crude total tRNA was added 1:1 with LiCl reagent
(1.25 M LiCl, 25 mM Tris-HCl pH 8.0, 2% triton X-100, 31.25 mM EDTA pH 8.0 final
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concentrations), followed by gentle mixing. Large RNAs were allowed to precipitate from these
solutions for 10 min on ice. Precipitations were subsequently centrifuged at 16,000 x g for 20 min
at 4°C. Following this, samples routinely contain a visible pellet. The supernatant, now enriched
for smaller RNAs, was collected and precipitated overnight at -20°C using NaOAc/ethanol as
already described. The resulting pellets were rinse with 70% ethanol twice, allowed to dry, and
resuspended in 16 µL of AEB. Pellets resulting from the large RNA precipitation were also rinsed
twice with 70% ethanol, allowed to dry, and resuspended in 50 µL AEB. The resulting RNA
solutions (large and small) were assessed for concentration and purity as described. RNase free
DNase I (NEB) was then used to remove gDNA from the total small RNA. Reactions were
constructed as recommended by the manufacturer and were allowed to incubate at 37°C for 1 hr.
Digested samples were precipitated, rinsed, and resuspended in AEB. All samples were visualized
via agarose-bleach gels.
Electrophoretic mobility shift assays and Microscale thermophoresis
To understand the capacity for LeuRS-I to bind tRNALeu molecules, both electrophoretic
mobility shift assays (EMSA) and microscale thermophoresis (MST) were employed.
Method I: Electrophoretic mobility shift assays using radiolabeled tRNALeu-UAG and SYBR
Gold
A reliable buffering system for running high quality polyacrylamide gels was required for
reproducible results within EMSA experiments. The major buffering system initially tested to
assess the quality of sample electrophoresis was a 3-(N-morpholino)propanesulfonic acid (MOPS)
system and a tris/borate/magnesium (TBM) system. Stock buffers at a 5x concentration were made
and diluted to 1x (MOPS – 100 mM MOPS free acid, 25 mM sodium acetate, 5 mM EDTA, 5mM
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MgCl2; TBM – 89 mM Tris base, 200 mM boric acid, 5 mM MgCl2). These buffering systems
were consistent throughout EMSA experiments unless otherwise noted.
Along with the different buffering systems, two major polyacrylamide gel (PAG) systems
were tested for suitability within EMSA experiments. Gel compositions varied as experimental
conditions were panned. Initial gel systems included a tris-borate (TB) and a bis-tris methane (bistris) buffered PAG environment. Bis-tris gels were tested at pHs of 7.6 and 6.5. Initial EMSA gels
were comprised of 0.5x TB buffer (44.5 mM tris base, 100 mM borate), 5% acrylamide (37.5:1
acrylamide:bisacrylamide vol/vol), 2% glycerol (vol/vol), and 15 mM MgCl2. Acrylamide
polymerization was induced with the addition of 0.001% APS (vol/vol) and 0.001% TEMED
(vol/vol) after taking the gel solution to 15 mL with ddH2O. Equivalent Bis-tris gels (pH 7.6 and
6.5) were also utilized using the same concentrations of reagents.
Previously generated 5’ [32P]-Si tRNALeu-UAG isoacceptor was utilized as substrate for
assessing the ability of LeuRS-I to bind tRNA via EMSA. A 5x supplemental buffer was made to
produce a suitable environment conducive for binding between LeuRS-I and tRNALeu-UAG, with
a 5X reaction consisting of 295 µM MES, pH 6.7, 75 µM ZnSO4 and 20 µM NaCl. A 10X tRNA
folding mix was assembled with final 200 nM 5’ [32P]-Si tRNALeu-UAG (hot UAG) and 300 nM
non-radiolabeled tRNALeu-UAG (cold UAG) 5 mM MgCl2, 10 mM MES and was taken to a final
volume of 100 µL with dH2O. Water was brought to a vigorous boil and the temperature was
monitored using a thermometer. When the water bath reached 93°C, the previously assembled 10X
tRNA mix was inserted for three minutes. Subsequently, the waterbath, now containing the tRNA
mix, was placed on ice and allowed to cool to room temperature. Ten PCR tubes were placed in
series, the first of which contained 10 µL of 8.8 µM LeuRS-I to assess the coherence of EMSA.
All other tubes in series were aliquoted with 5 µL of protein storage buffer and were two fold
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diluted with an initial volume of 5 µL LeuRS-I at 8.8 µM. From these tubes, 4 µL of protein/buffer
mix was removed and combined with 2 µL of 10X folding mix and 2 µL of dH2O, then was allowed
to incubate at room temperature for 30 minutes. Following incubation, 2 µL of bromophenol blue
dye (360 mM MES pH 6.5, 60% glycerol, 0.00001% bromophenol blue) was added to the
reactions. Prior to sample electrophoresis with a TBM system (5X buffer stock at pH 7.6), a bistris gel was made using the previously mentioned recipe and was pre-run without samples in prechilled 0.5X TBM buffer on ice for 40 minutes at 100 V, afterwhich the total volume of each
sample was loaded and electrophoresed until the dye front approached the end of the plate. The
gel was immediately removed from the apparatus and dried on a Gel-drying system (Biorad Model
583 gel dryer) and placed in a FUJIX BAS casette 2040 phosphorscreen (Fujifilm Medical Systems
U.S.A., Inc.) for four hours. The phosphor screen was removed and scanned using a GE Typhoon
FLA 7000.
Due to a lack of shift appearing within the previously run TBM gel and an apparent lack
of migration of LeuRS-I into the gel during electrophoresis, a new round of EMSA was run using
the secondary MOPS buffering system with bis-tris gels, as well as varied acrylamide:bisacrylamide ratios in an attempt to aid in the migration of protein into the gel. Samples of protein
and tRNA were worked up using the previously mentioned protocol of serial dilution and were
composed of the same concentrations of reagents within both the folding mix and supplemental
buffers. However, LeuRS-F was substituted in place of LeuRS-I as a control with the expectation
of a clear shift being seen. Unlike the previously assembled samples, the final two tubes of the
dilution series comprised of both a tRNA control devoid of protein and a tube containing LeuRSF plus I-Ct antibody developed within the Weitzel laboratory, with the intention of possibly seeing
a supershift between the antibody and the protein. Reaction preparation followed the previous
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methods and utilized the same bis-tris gel system, however the gel compositions varied in ratios
of acrylamide:bis-acrylamide, with one gel containing a ratio of 29:1 and 37.5:1, respectively. Gels
were electrophoresed and imaged using the previously mentioned protocol.
Due to the jagged nature of the electrophoretic quality of the MOPS system with the bistris gels, it was determined that the gel composition may need to be attenuated to result in a more
consistent migration of sample. Because both the 29:1 and 37.5:1 acrylamide gels had the same
quality of jaggedness in band electrophoresis, it was determined that perhaps the glycerol in the
sample was effecting this. A 20% triethyleneglycol (TEG) solution was substituted in place of the
50% glycerol solution that was originally added to the gels due to its ability to stabilize nucleic
acid-protein complexes during electrophoresis as noted by Sidorova and cohort.[36] All other gel
components were maintained and used a standard 37.5:1 acrylamide solution. As compared to the
last experiment, all methods were maintained aside from 20% TEG or 50% glycerol addition to
the gel composition. LeuRS-I was used as the protein within these reactions.
Because of the lack of a discernable shift within EMSA using LeuRS-I and LeuRS-F, other
parameters of the reaction were augmented. One theory regarding the lack of gel shifting
postulated the possibility of improper folding of the tRNA molecules using the standard heating
and cooling method in boiling water, which was then modified experimentally. Utilizing the same
supplemental buffers as previously used, it was determined that two separate folding mixes should
be made, one of which would be heated and cooled using the same parameters as previously
mentioned, with the other being immediately flash-cooled after the initial 3 minutes of heating in
near-boiling water. Unlike the other protocols utilizing a ten tube serial dilution series, these
samples were only aliquoted into three tubes, the first of which was straight LeuRS-I protein, a
two-fold and a three-fold dilution, all of which were combined with supplemental buffer and the
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respective folding mixes. Samples were electrophoresed using the MOPS buffering system and a
bis-tris gel of standard makeup, as previously mentioned.
A common theme within previously run EMSA reactions was the large amount of
streaking, or tails, that would be seen in the gels. This streaking patterns’ eminence within the gels
proved to be very difficult to quell in all experimentation utilizing the hot UAG substrate, of which
a possibility existed in which degradation products of the hot UAG could be adding noise to the
shift assays. Therefore, it was determined that a radiation-free substrate would be required to assess
the quality of EMSA. The proprietary dye SYBR® Gold (Thermo Fisher Scientific) was utilized
as a safe and radiation-free alternative in assessing EMSA reactions.[37] SYBR Gold dye binds
with high fidelity to RNA and could be used in assessing any interaction between LeuRS-I and
tRNA molecules.[37] The stain was tested initially with varied concentrations of cold UAG to assess
the sensitivity and quality of staining of tRNA, as well as the quality of in-vitro transcribed
tRNALeu-UAG isoacceptor. TBM gels were assembled under standard procedure and both folded
and unfolded samples of cold UAG were generated. A condition of supplemental buffer addition
and subtraction from the samples was also used to assess quality of the tRNA’s environment and
the effect of the supplemental buffer on the electrophoresis quality. Using the standard
concentrations of reagents within the supplemental buffers, the cold UAG was aliquoted in varied
concentrations and reagent conditions. A total of 12µL of sample was loaded on a TBM gel and
was electrophoresed under standard conditions. SYBR Gold was diluted 1:100 in a 1X TAE buffer,
and the gels were stained for 30 minutes.
Due to the quality of the SYBR Gold treatment on the cold UAG substrate, it was
determined that EMSA utilizing LeuRS-I was feasible. Samples were prepared under the standard
procedure of serial dilution and contained the original folding mix reagents as well as supplemental
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buffer reagents. The final dilution tube in series contained a tRNA control devoid of protein.
Samples were run using the MOPS / bis-tris system and were stained using SYBR Gold at the
previously mentioned concentrations and times.
In determining the quality of the shift between the cold UAG and LeuRS-I, the expected
decrease in signal of the lower tRNA bands within the higher concentration protein lanes was not
easily seen. Therefore, it was determined that a control gel in which only protein was loaded could
untangle whether the SYBR Gold reagent was specific to binding only the tRNA in the sample, or
if it is binding to the protein as well and giving a “false shift”. The process of working up the
dilutions of protein was repeated as previously mentioned but lacked the addition of folding mix
and tRNA to the samples. The samples were run using the same MOPS / bis-tris system and were
electrophoresed and stained using the sample protocol as previously mentioned.
The seeming lack of migration of the protein samples into the acrylamide gels, either
utilizing the bis-tris or the TBM gels, had yet to be alleviated. A custom-made sequencing TB
acrylamide gel (75:1 acrylamide:bis-acrylamide), was utilized to determine the migrational
properties of LeuRS-I, LeuRS-F, and a control E. coli LeuRS. Samples were serial diluted using
protein storage buffers with initial protein concentrations of LeuRS-F at 160 µM, LeuRS-I at 20
µM, and E. coli LeuRS at 86 µM. A total of 20µL of each sample was loaded on a 22x20 short
plate TBM sequencing gel with 0.4 mm spacers and was electrophoresed for 8 hours at 800 V in
the cold room. The gel was then stained for thirty minutes using a Coomassie Brilliant Blue stain
solution (0.1% Coomassie Brilliant Blue R-250, 50% methanol, 10% glacial acetic acid) and a 1
hour destain using a solution containing 40% methanol and 10% glacial acetic acid. The gel was
then dried using a Biorad model 583 gel dryer.
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Method II: Microscale thermophoresis (MST)
Given the difficulties of assessing tRNA binding by LeuRS-F/I via EMSA, microscale
thermophoresis (MST) was employed as an alternative means of gauging these interactions.
However, this methodology was deemed impossible due to the intrinsic fluorescence of both
LeuRS-F and LeuRS-I decreasing following the titration of the proteins with higher concentrations
of tRNA. Therefore, a secondary method detecting fluorescence quenching of tryptophan residues
on the proteins following the potential binding of tRNALeu-UAG substrate was performed utilizing
the Monolith NT.Label Free (NanoTemper Technologies) instrument. Binding reactions were
assembled using 15mM MgCl2, 10 µM ZnSO4, 25mM NaCl, 2mM DTT, 12.5% glycerol, 60mM
MES (pH 6.5), 0.1% pluronic F-127, in vitro transcribed tRNALeu-UAG, and 500nM LeuRS-F or
LeuRS-I. A set of three varied concentrations of folded tRNALeu-UAG substrate was utilized in a
range from 75 µM to 0.59 µM. All binding reactions proceeded with were incubated at room
temperature for at least 1 hour and were loaded into standard-treated capillaries (NanoTemper
Technologies). NT analysis software provided by NanoTemper Technologies was used to
aggregate the fluorescence scans generated by the instrument and to normalize the complexed
molecule fraction. Three biological replicates were then introduced into KaleidaGraph (Synergy
Software) and were fitted to the Hill equation to asses binding affinities of the protein and tRNA
molecules. Remaining portions of binding reactions were then subjected to an SD denaturing
protocol to ensure that fluorescence quenching was indeed was a result of protein-tRNA interaction
and not errant precipitation of the protein sample under heightened tRNA concentrations. Binding
reactions were centrifuged at 14,000 rpm for 11 minutes, with a portion of this reaction combined
to equal volumes of SD buffer (40mM DTT and 4% SDS) reagents, then heated at 95°C for 5
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minutes. Samples were then loaded into capillaries and scanned using the Monolith NT.Label Free
instrument.
Phylogenetic analyses of LeuRS within the Sulfolobaceae
As a means of assessing the prevalence of this paralogous synthetase amongst different
strains of S. islandicus and other members of the family, phylogenetic analysis of 39 family
members of the Sulfolobaceae was performed.
Method I: Sequence gathering and phylogeny generation
For phylogenetic analysis, the open source software known as Mega X: Molecular
Evolutionary Genetics Analysis was used.[38] Sequences with considerable homology to S.
islandicus LeuRS-F and LeuRS-I were identified and retrieved from each family member
analyzed. A variety of online databases were utilized for sequence collection, including Uniprot,
NCBI, and KEGG.[39,40,41]
Because of a lack of annotation of certain sequences, the identity of LeuRS-I had to be
determined manually by assessing the substitutions of critical amino acids in the CP1 domain that
are central for the editing capacity of these proteins, namely the conserved aspartic acid at position
315 which is substituted with histidine in LeuRS-I.[15,16] The compiled sequences were aligned
within Mega X and, using the nearest neighbor analysis method with a 1000 iteration bootstrap
phylogeny test and Poisson modelling, the phylogeny was generated. Poisson modelling is a
regression analysis that models response variables and indicates which explanatory variables are
statistically significant.[42] Condensed tree formatting was employed at a 75% cutoff score for
producing the phylogeny. This cutoff score reflects only sequences that the program assesses as
having a 75% confidence of being at a given position.
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Generation of a LeuRS-I antibody
For tracking the in vivo expression of LeuRS-I, the amino acid sequence corresponding to
the C-terminal fragment, residues 789 – 934, of LeuRS-I was cloned into pET14b(+) (Novagen)
generating a clone fused to an N-terminal His-tag. This clone was transformed and overexpressed
in E. coli BL21(DE3) (New England Biolabs) and subsequently purified for the production of
polyclonal antibodies (Pierce Custom Antibodies). This particular sequences was chosen to
decrease the chances of cross reactivity with LeuRS-F.
Method I: Transformation and overexpression
Ten milliliters of an E. coli BL21(DE3) starter culture harboring a plasmid coding for the
C-terminal domain of LeuRS-I [His6-LeuRS-I (789-934)] was inoculated into 1L of lysogeny broth
(LB) and allowed to grow at 37°C with aeration at 250 rpm until an OD600 of 0.433 was reached.
At this time, protein expression was induced with 400 µM isopropyl β-D-1-thiogalactopyranoside
(IPTG).[43] Induced cultures were shifted to room temperature and allowed to grow overnight with
aeration 125 rpm. Cells were harvested on the subsequent day via centrifugation at 4250 rpm for
45 minutes at 4°C. The cell pellet was resuspended in 20 mL of lysis buffer (300 mM NaCl, 50
mM Na2HPO4, 10 mM imidazole, 10% glycerol, pH 8.0) and froze at -20°C. Cells were thawed
and doped with 1mM Phenylmethylsulfonyl fluoride, 1mg/mL lysozyme and 1 Pierce protease
inhibitor pill, then was subsequently lysed via sonication using a Fisher Scientific Sonic
Dismembrator. Sonication parameters included 30% power for a total of 4 minutes of sonication
time in 30 second intervals of on / off states to release the expressed protein into the soluble
fraction. Lysates were cleared via centrifugation at 14,000 x g for 30 minutes.
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Method II: Affinity purification of overexpressed protein
For selective purification of the overexpressed protein, an agarose NTA-Ni2+ column with
a 2 mL bed volume was utilized to capture the His-tagged LeuRS-I (789-934) fragment from the
lysate. To begin, the soluble fraction of the cleared and centrifuged lysate was loaded on the nickel
column and allowed to flow through. The column was subsequently rinsed as follows: 20 mL lysis
buffer, 10 mL imidazole wash buffer 1 (10 mM imidazole, 300 mM NaCl, 50 mM Na2HPO4, 10%
glycerol, pH 8.0), 10 mL imidazole wash buffer 2 (15 mM imidazole, maintaining same salt
concentrations), and imidazole wash buffer 3 (20 mM imidazole, maintaining same salt
concentrations), and was subsequently eluted in 10 mL of elution buffer (250 mM imidazole, 300
mM NaCl, 50 mM Na2HPO4, 10% glycerol, pH 8.0). A 15% SDS-PAGE was used to track the
affinity purification of this protein. The C-terminal fragment is 19.2 kD in size. After confirmation
of the presence His6-LeuRS-I (789-934) post purification, the protein was dialyzed into phosphate
buffered saline (PBS; 137 mM NaCl, 2.58 mM KCl, 10.14 mM Na2HPO4, 1.76 mM KH2PO4, pH
7.4), supplemented with 1 mM dithiothreitol (DTT), 2 mM EDTA, and 10% glycerol. Upon
completion of dialysis, protein concentrations were determined using a BioRad Bradford assay
using the manufacturer protocol.
Method III: Thrombin digestion
The purified protein contains a thrombin cleavage site between the His-tag and the desired
protein sequence. Therefore, to generate a protein more closely resembling the wild type LeuRSI C-terminal domain fragment, the fusion protein was subsequently processed with 2 units of
biotinylated thrombin to remove the His-tag. Cleavage kinetics were followed via 15% SDSPAGE over a 16-hour time course. Biotinylated thrombin was removed from solution by adding
200 µL of streptavidin coated agarose beads (Novagen) and capturing the bead-streptavidin-
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biotinylated thrombin complex using filter-containing microfuge spin columns (Novagen).
Liberated His-tag and uncleaved His-LeuRS-I (789-934) was captured using agarose Ni-NTA2+
resin, leaving only the desired C-terminal fragment of LeuRS-I as determine via PAGE analysis.
The collected protein was dialyzed using protein storage buffer (15 mM NaCl, 2.58 mM
KCl, 10.14 mM Na2HPO4, 1.76 mM KH2PO4), pH 7.4, supplemented with 1 mM DTT, 1 mM
EDTA, and 10% glycerol and was further purified via anion exchange chromatography using
diethylaminoethyl (DEAE) resin. A step gradient was used to elute bound LeuRS-I (789-934) from
this column in a range from 75mM NaCl to 1M NaCl. Subsequent PAGE analysis determined that
the LeuRS-I (789-934) eluted from the DEAE column at a salt concentration of 75 mM sodium
chloride. The digested and purified C-terminal domain of LeuRS-I was pooled and dialyzed
against PBS, 5% glycerol, 1 mM DTT, and 2 mM EDTA, pH 7.5. The protein was used to
immunize rabbits for the production of polyclonal antibodies specific to this domain (Pierce
Custom Antibodies, 90-day rabbit protocol, 2 rabbits).
Generation of a S. islandicus genomic C-terminal HA-tagged LeuRS-I (I-Ct-HA)
The construction of a tagged genomic version of LeuRS-I (I-Ct-HA) is of importance for
a variety of biological assays and can be used in conjunction with a previously generated Cterminal FLAG-tagged LeuRS-F strain (F-Ct-FLAG).
Method I: Plasmid construction
Through recombinant DNA cloning, a plasmid was constructed for introduction of an
Hemagglutinin-tag (HA-tag) fused to the C-terminus of LeuRS-I. This HA-tag consists of 9 amino
acids (YPYDVPDYA) and can be readily detected with commercially available antibodies. Vector
pRJW08, an E. coli – S. islandicus suicide vector, can be actively propagated in E. coli but not S.
islandicus.[11] A 1.68 kilobase pair (kbp) fragment was synthesized (IDT, referred to as gBlock),
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consisting of a 730 bp 3’ LeuRS-I gene fragment (target gene; Tg) fused to the HA-tag sequence
and a 868 bp downstream (D1) fragment. The gBlock fragment was diluted to 100 µM with a 10
mM Tris-HCl buffer, pH 8.8. Ten fmol of amplified, Dpn1 digested, and cleaned pRJW08 vector
was combined with 30 fmol of pre-diluted gBlock fragment, 1X HiFi Gibson master mix (NEB)
and taken to a final volume of 10 µL with ddH2O. The reaction was run on a BioRad C1000 Touch
thermocycler for 30 minutes at 50°C. E. coli Endura chemically competent cells (Lucigen) were
transformed with 2 μL of this reaction according to the manufacturer’s recommendations in the
hopes of isolating successfully constructed recombinant plasmids. Endura cells were used as they
possess a genotype that appears capable of maintaining toxic DNA products. Transformations were
plated on LB agar supplemented with 100 μg/mL carbenicillin and incubated overnight at both
37°C and room temperature. Colony PCR was used to screen resulting colonies for successfully
constructed recombinant clones. Prior to using colonies as template for these PCR reactions, they
were patch-struck onto fresh 100 μg/mL LB-carbenicillin plates. Remaining portions of colonies
were resuspended in 10 µL of ddH2O generating PCR templates. Twenty microliter reactions
contained 5 µL of resuspended colony template, 0.5 µM primer M9, 0.5 µM primer REV99, and
1X GoTaq mastermix (NEB). Thermocycler settings included an initial melting temperature of
95°C for 2 minutes, melting temperature of 95°C for 30 seconds, annealing temperature of 55°C
for 35 seconds, extension temperature of 72°C for 2 minutes and 20 seconds for 39 cycles, a final
extension at 72°C for 3 minutes followed by a hold at 4°C. Samples were loaded into a 1% (wt/vol)
agarose LE gel in 1X TAE and were electrophoresed for 40 minutes. DNA was stained using
ethidium bromide (EtBr, 1µg/mL in ddH2O bath) and subsequently imaged on a UVP GelDoc-IT
system.
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Colony patches corresponding to positive screens were subsequently grown overnight at
37°C with aeration in 5 mL LB supplemented with 100 μg/mL carbenicillin. Three to four
milliliters of this overnight culture was used to isolate plasmid DNA using an IBI miniprep kit
according to the manufacturers instructions. DNA was eluted in 40 µL of pre-warmed elution
buffer. Samples were given identities based on the condition at which the colony was initially
grown (RT and IC for room temperature and incubator), as well as a number descriptor for the
colony identity. Samples included RT1, RT2, IC1, and IC2. Isolated plasmids were PCR screened
for the gBlock fragment as previously described. IC1 was sequence verified via Sanger sequencing
at the University of Illinois, Urbana-Champaign (UIUC) Core DNA facility and was subsequently
carried forward in additional cloning steps.
pRJW08-gBlock(+) was double digested in 20 µL reactions using the endonucleases SalIHF (NEB, 20 units) and XmaI (NEB, 10 units) in 1X CutSmart buffer (NEB). Reactions were
incubated at 37°C for 4 hours and were subsequently purified using an IBI PCR cleanup kit
following the manufacturer’s protocol. Digested DNA was eluted in a final volume of 30 µL using
prewarmed elution buffer (10mM Tris-HCl pH 8.8).
To complete the plasmid needed to insert the HA-tag onto the C-terminus of LeuRS-I, an
identical downstream fragment as D1 (D2) containing terminal SalI and XmaI restriction sites was
required. This DNA fragment makes the suicide vector proficient for recombination with the S.
islandicus genome. Previously isolated gDNA from S. islandicus M16.4 strain was used as the
template for amplification of this D2 fragment. PCR reactions contained 1X Q5 Buffer (NEB), 1X
Q5 enhancer (NEB), 0.2 mM dNTP mix, 50 ng S. islandicus gDNA, 0.5 µM primer M57, 0.5 µM
primer M58, and 1 U Q5 DNA Polymerase (NEB). Reactions were run on a minicycler program
including an initial melt at 98°C for 2 minutes followed by 29 cycles of the following: 98°C for
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30 seconds, 55°C for 30 seconds, 72°C for 1 minute. A final extension at 72°C for 5 minutes was
subsequently followed by an infinite incubation at 4°C. After PCR amplification, product quantity
and purity were qualitatively assessed using 1% (wt/vol) agarose gel electrophoresis. Afterwards,
amplified D2 fragment was purified using an IBI PCR cleanup kit, again, following the provided
manufacturer’s protocol. DNA was eluted in 20 µL of pre-warmed elution buffer and double
digested at 37°C overnight using 20 units of SalI and 10 units of XmaI.
Double digested pRJW08-gBlock(+) (10 fmol) and D2 (40 fmol) were ligated in 10 μL
reactions containing the indicated amounts of DNA, 1X T4 DNA Ligase buffer, and 400 U of T4
DNA Ligase. Ligations were incubated at room temperature for 30 minutes followed by a 15 min
incubation at 65°C to heat kill the ligase. E. coli Stop Unwanted Rearrangement Event competent
cells (SURE2, Agilent) were transformed with (2 μL) of this ligation reaction following standard
transformation protocols. Transformed cells were selected on LB agar plates supplemented with
100 μg/mL carbenicillin at 37°C overnight. Colony PCR was executed on resulting colonies using
GoTaq master mix and primer pair M87 and FOR88. Successfully screened colonies were grown
and miniprepped, and one of the acquired recombinant clones was sequence verified at UIUC’s
Core DNA facility.
Method II: Transformation of pRJW08-gBlock/D2(+) into wild type S. islandicus
Following construction of plasmid pRJW08-gBlock/D2(+) (HA-I), wild type S. islandicus
M.16.4 (RJW04, ΔpyrEFΔlacSΔargD)[11] was prepared for transformation. Wild type cells were
recouped from freezer stocks as previously described and subsequently passaged into 20 mL
DT/AU medium. Cells were grown at 75°C to an OD600 of 0.350 and were harvested via
centrifugation at 8,000 x g for 15 minutes at 4°C. Following centrifugation, the cell pellet was
rinsed with 15 mL of 20 mM sucrose thrice, decanting the sucrose supernatant after each
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subsequent centrifugation step. Cells were resuspended in a final volume of 1 mL 20 mM sucrose
and were carried forward for transformation.
The HA-I vector required linearization prior to its introduction into the genome of wild
type S. islandicus. Roughly 8.5 µg of recuperated HA-I was digested using 20 units of XmaI. The
digestion was incubated at 37°C overnight and was subsequently purified using a Monarch PCR
cleanup kit (NEB). The standard protocol provided by the manufacturer was utilized, eluting in a
final volume of 20 µL with pre-warmed elution buffer (10 mM Tris-HCl pH 8.8). Sample
concentration and purity was determined using a NanoDrop One and the preloaded dsDNA
protocol.
Aliquots of S. islandicus (50 µL) in sucrose were combined with 1 µg, 1.5 µg, and 2.0 µg
total linearized HA-I for transformations. Cells and DNA were incubated on ice for 30 minutes.
Following incubation, the cells and DNA mix were transferred to electroporation cuvettes (0.1 cm
gap size, GenePulser Xcell) and were electroporated using a Gene Pulser (BioRad) set to 1.2 kV,
25 µF and 600 Ω. Cells were removed from the electroporation cuvette and incubated in 950 µL
of 75°C recovery medium (1% w/v sucrose, 20 mM beta-alanine, 1.5 mM malic acid, 10 mM
MgSO4, pH 4.5) and were allowed to incubate at 75°C for 30 minutes. 5 mL of freshly autoclaved
and sterilized 0.8% (wt/vol) Gelzan (Sigma-Aldrich) solution and 5 mL of 2X Basal 4 DT media
(0.000002% trace metal, 0.3% K2SO4, 0.05% NaH2PO4, 0.1405% MgSO4, 0.048% CaCl2•2H2O,
0.1% EZMix N-Z-Amine A, 0.1% Dextrin, wt/vol) pH 2.6 was aliquoted for each transformation
and placed at 75°C for 30 minutes. After incubation had concluded, the cells were removed from
the incubator along with the Gelzan and 2X Basal 4 DT solutions, all of which were combined in
the laminar flow hood and poured over DT plates that had been thoroughly pre-heated at 75°C.
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Overlays containing transformed cells were allowed to solidify and were subsequently incubated
at 75°C for 2 weeks.
Following the extended incubation, embedded colonies were noted on both the 1 µg and
1.5 µg transformation plates and were harvested via pipetting and transferred into 2 mL of DT
media. Cells were allowed to grow until cloudy and were stained with 2 µM 5-bromo-4-chloro-3indolyl-β-D-galactopyranoside (X-gal) resuspended in DMSO. The presence of blue staining
indicates a cell with the HA-I vector integrated within its genome. Positive cells were transferred
to 20 mL of DT media and grown in the 75°C incubator until noticeably cloudy. After reaching an
OD600 of roughly 0.400, the cells were harvested via centrifugation under the previously mentioned
parameters and were resuspended in 1 mL of sucrose for colony purification. 30 µL of the sucrose
resuspended cells were then added to a 96-well plate and 10-fold serial-diluted into 20 mM sucrose.
200 µL of the 10-4, 10-5, and 10-6 dilutions were plated onto fresh DT plates and allowed to dry
under flame. Plates were double bagged and placed at 75°C for one week after which large
numbers of colonies were observed. Purified colonies were harvested as previously noted and
grown in 20 mL of DT medium.
Removal of unnecessary plasmid-borne components still present within the genome of
these transformant wild type cells was required. Counterselection was achieved by first
transferring 30µL of each transformant to a 96-well plate and ten-fold serially diluting to the 10-6
with 270 µL of 20 mM sucrose as diluent. 200 µL of the 10-4, 10-5, and 10-6 dilutions were used as
inoculants into overlays containing 0.8% gelzan and 2X basal 4 counterselection medium
(0.000002% trace metal, 0.3% K2SO4, 0.05% NaH2PO4, 0.1405% MgSO4, 0.048% CaCl2•2H2O,
0.1% EZMix N-Z-Amine A, 0.1% dextrin, 50 µg/mL 5-Fluoroorotic acid (5-FOA), 20 µg/mL
uracil, and 1 mg/mL agmatine, wt/vol), Overlays were mixed and poured over DT/AU
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counterselection plates consisting of the same media. Plates were double-bagged and placed at
75°C and allowed to grow for approximately one week, after which colonies were harvested and
grown in standard DT/AU medium. Screening of the strains for the integrated and LeuRS-I fused
HA-tag was achieved via PCR using primer pair M97 and LRSI 1724. The integrity of all regions
of the chromosome involved in the recombination, including the integrated HA-tag, were sequence
confirmed at UIUC’s Core DNA facilities.
Growth curve of S. islandicus LeuRS-I-Ct-HA strain
To assess the growth phenotype of the newly generated HA-I strain, a growth curve
utilizing triplicate growth flasks of both the HA-I and S. islandicus wild type strain at the stressful
temperature of 60°C was performed. Cells were inoculated into DT/AU medium, pH 3.25 from
freezer stocks using the previously mentioned protocol and were subsequently transferred to cell
culturing flasks containing 20 mL DT/AU media, pH 3.25. Passage 2 cells and were harvested at
an OD600nm of 0.290 and 0.235 for S. islandicus wild type and the HA-I strain, respectively, and
rinsed with sucrose as previously described. Prepped cells were inoculated in triplicate into 50 mL
of DT/AU medium, pH 3.25 and placed in an incubator shaker set to 60°C and 250 rpm. Flasks
were tracked for OD600nm over the course of 9 days at the same time on each day.
Expression profiling of the HA-I strain using Western blots
To determine the relative expression of LeuRS-I in vivo and whether this expression is
modulated by the abiotic stress of low growth temperatures, HA-I and FLAG-F strains of S.
islandicus were utilized in a comparative Western blot.
Method I: Western blot analysis of fusion protein expression
Semi-thawed freezer stocks (100 µL) of both HA-I (strain #86) and FLAG-F (strain #19)
strains were used to inoculate 2 mL of DT/AU medium and grown at 75°C. After visible cell
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growth, 1 mL of each starter culture was passaged into 20 mL of DT/AU medium at incubated at
75°C. Cells were grown to approximate OD600s of 0.350 and were harvested via centrifugation and
washed as described above using 20 mM sucrose. OD600s of the final sucrose-resuspended cells
were taken. Six flasks each of FLAG-F and HA-I were inoculated to initial OD600s of 0.008 using
150 mL of DT/AU medium. Three of each set were placed at 75°C while the other three were
placed at 60°C with aeration (250 rpm). Samples were monitored and harvested via centrifugation
at lag, log, and early stationary phases (OD600s of 0.15-0.18, 0.25-0.35, and 0.42-0.55,
respectively). A single culture for strain #86 grown at 60°C was noted as losing volume.
Five milliliters of lysis buffer (300 mM NaCl, 50 mM Na2HPO4, 10 mM imidazole, 10%
glycerol, pH 8.0) was added to harvested cell pellets. The cellular resuspensions were
supplemented with a single protease inhibitor cocktail pill (Pierce) and PMSF at a final
concentration of 1 mM. The culture that lost significant amounts of volume was resuspended in
only 2.5 mL of this lysis buffer cocktail as a means of standardizing the samples. Samples were
incubated on ice for 30 min and were then lysed using a sonic dismembrator at 30% power with 4
minutes of processing time with cycles of 30 seconds on and 30 seconds off. Tubes containing the
lysed milieu were then placed on ice and spiked with Triton X-100 (Biorad) to a final concentration
of 0.2 % (vol/vol). These samples were incubated on ice and were gently mixed using a benchtop
shaker (SHKE2000, ThermoFisher) set to 75 rpm. Following a 2-hour incubation on ice, cells were
centrifuged at 8,000 x g for 40 minutes at 4°C and the soluble supernatants were collected and
transferred to fresh 15 mL falcon tubes.
Protein was quantified using a modified Bradford assay (BioRad).[44] Due to the presence
of Triton X-100 within cleared lysates and the incompatibility of the BioRad reagent to this
compound, beta-cyclodextrin was added to all samples at a final concentration of 1.76 mM.[45]
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Beta-cyclodextrin acts as a molecular sponge for detergents in solution, binding to detergents such
as SDS and Triton X-100 in a 1:1 molar ratio. This chemical additive aids in reducing the
interference induced by detergents such as Triton X-100 when measuring absorbances on a
spectrophotometer during Bradford assays. Approximate protein concentrations were gathered and
normalized. A total of 1.5 µg of total protein for each sample was analyzed via 8% SDS-PAGE.
Separated proteins were transferred to polyvinylidene difluoride (PVDF) membrane and blocked
overnight at 4°C in Tris-buffered saline (TBS) supplemented with bovine serum albumin (TBSBSA, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% BSA). Target proteins were probed with either
monoclonal rat anti-HA primary antibody (1:2000, Sigma, Cat# 11867423001) or monoclonal
mouse anti-FLAG primary antibody (1:2000, Sigma, Cat# F3165) resuspended in TBS-BSA and
rinse steps utilized TBS supplemented with 0.2% Tween-20 (TBS-T, BioRad). Horse radish
peroxidase (HRP) conjugated goat anti-mouse and goat anti-rat secondary antibodies (KPL) at a
1:10,000 dilution in TBS-BSA, ECL chemiluminescent substrate (West Pico Plus, Thermo Fisher),
X-ray film (Research Products International, Cat# 248304) and an automatic X-ray film developer
were used to develop blots. Densitometry analysis of HA-I protein was performed using FIJI (Fiji
is just ImageJ).[46] Areas surrounding the bands present on the blot were standardized in size
amongst all data sampling points, with histograms generated for each subsequent sample band.
Histogram intensity plots were then measured by setting a cutoff at the rise and fall of each end of
the histogram. A background subtraction was taken by sampling a blank portion of the blot and
subtracting the blank’s intensity from each of the densitometric readings gathered for each sample.
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CHAPTER III: RESULTS AND DISCUSSION
Development of a phylogenetic tree comparing LeuRS-F and LeuRS-I in the Sulfolobaceae
As a means of assessing the prevalence of this paralogous synthetase amongst different
strains of S. islandicus and other members of the family, phylogenetic analysis of 39 family
members of the Sulfolobaceae was performed. A preliminary investigation was tasked as a means
of determining whether this duplication event is a localized aberration shared between only closely
related species and strains or if this genetic event is widespread and maintained beyond the genus.
Genomic comparative analysis has shown that this duplication event of the LeuRS gene is
conserved across all family members of the Sulfolobaceae, including those of the genus acidianus
and metallosphaera (Figure 2). This duplication’s omnipresence amongst Sulfolobaceae family
members provides a strong indication of importance as indicated by its maintenance across
evolutionary timescales in these organisms. Upon analysis, there is a clear and distinct
evolutionary trajectory that each of these synthetases are following when comparing the sequences
derived from these different species. Clustering of LeuRS-F and LeuRS-I into specific groups is
apparent, and the trend of demarcation of the two enzymes is total. The clustering of similar species
such as the different strains of S. islandicus is also ostensible, showing a closer relation to one
another within each of these groupings as compared to different species such as Acidianus or
Solfataricus. Interestingly, the positions of LeuRS-I and LeuRS-F of the Metallosphaera species
cluster differently, with branching of Metallosphaera LeuRS-I along with the Acidocaldarius
strains, while LeuRS-F clusters with Acidianus strains.
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Figure 2. A phylogeny consisting of the LeuRS-I and LeuRS-F enzymes across the family
Sulfolobaceae
A Mega X phylogenetic analysis of LeuRS-I and LeuRS-F across a variety of different species
(39) within the family Sulfolobaceae. Bootstrap values are shown at node points relaying
confidence of the strain’s placement in its position. S – Sulfolobus. M – Metallosphaera. A –
Acidianus. Colors: Orange – LeuRS-F; Blue – LeuRS-I.
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Electrophoretic mobility shift assays
Due to the inability of LeuRS-I to aminoacylate in vitro transcribed tRNALeu, a question of
whether this enzyme is capable of binding tRNA at all has been raised. The logical assessment of
this issue would be that LeuRS-I is incapable of binding tRNALeu and therefore cannot complete
the charging of leucine onto the cognate tRNA. In an attempt to assess the ability of LeuRS-I to
bind tRNALeu substrates, electrophoretic mobility shift assays (EMSA) were employed. The
principle of EMSA is such that the interaction of both a protein and nucleic acid species can be
visualized on Native-PAGE as a “shift” or a banding pattern that presents itself as a higher
molecular weight than merely the protein or nucleic acid alone.[49] This higher weight band
signifies the binding interaction between the protein and nucleic acid substrate. This technique has
been used to assess the binding affinities of other tRNA synthetases to their respective tRNA
substrates.[50]
To begin, a TBM gel was run with 2-fold serial diluted LeuRS-I and a consistent quantity
of radiolabeled in vitro transcribed tRNALeu-UAG. Reaction conditions included a supplemental
buffer consisting of 295 µM MES, pH 6.7, 75 µM ZnSO4 and 20 µM NaCl and a 10x folding mix
comprised of 10 µM non-radiolabeled tRNAleu-UAG (cold UAG) and 10 µM radiolabeled
tRNALeu-UAG (hot UAG), 5 µM MgCl2, 10 µM MES. The TBM gel was noted as having illdefined resolution and failed to show a clear and well-defined shift representing the interaction
between LeuRS-I and this tRNA substrate. However, it was clear that a minor portion of the tRNA
was aggregating, represented as signal in some of the gel wells (Figure 3). The doublet near the
bottom of the gel is representative of the radiolabeled tRNA. The top band of the two represents
the functional tRNA substrate as deduced from its disappearance in lane one which contains the
highest concentration of LeuRS-I (Figure 3). The bottom of the two bands likely represents a
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degraded tRNALeu-UAG variant that was labeled during the kinase reaction. Alternatively, this
band may represent the full-length tRNA that has adopted a different tertiary structure. As alluded
to above, although no discernable shift was apparent, lane one of the TBM gel containing undiluted
protein with tRNA presents itself as the most “non-mobile” sample as noted by the highest
intensity of tRNA substrate at the top of the gel. Subsequent lanes consist of two-fold diluted
protein.
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Figure 3. A 5% TBM EMSA gel monitoring the binding of LeuRS-I and [32P]-tRNALeuUAG.
A 5% TBM gel comprised of 37.5:1 acrylamide:bisacrylamide run with a 0.5x TBM buffer until
dye front approached the bottom of the plate. Gel contains a full set of serial diluted protein from
lane 1 – 10. A total of 50 nM tRNALeu-UAG was utilized in addition to each of the protein samples.
Lane 1 consists of 4.4µM final protein, lane 2 equates to 2.2µM final protein and subsequent lanes
follow 2-fold dilutions. Lane 10 consists of a final protein concentration of 0.0085µM.
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To further explore and optimize the EMSA system, a secondary gel buffered with a bis-tris
solution and utilizing a MOPS running buffer was employed. Two separate gels of varied
acrylamide:bisacrylamide ratios were made in order to modulate pore size and LeuRS-F was used
knowing that this synthetase robustly charges tRNALeu and must, therefore, bind this substrate
(Figures 4 and 5). While a discernable gel shift was not apparent, radioactive signal was detected
in lanes 1 – 5, indicating that LeuRS-F bound radiolabeled tRNALeu-UAG. However, due to the
poor quality of both gels and the inability of the LeuRS-tRNA complex to migrate beyond the
wells, binding affinities could not be calculated. In fact, discernable free tRNA bands were difficult
to distinguish. It was also clear that neither ratio of acrylamide:bisacrylamide used to pour these
gels affected the observed migration patterns.
Next, bis-tris gels were poured using a consistent acrylamide:bisacrylamide ratio (37.5:1)
supplemented with either glycerol or triethylene glycol (TEG), which has been previously reported
as a stabilizing factor in DNA-protein complexing.[36] Assays used consistent quantities of [32P]tRNALeu-UAG and LeuRS-I (Figures 6 and 7). As before, EMSA results were less than ideal. At
the concentration of TEG tested (20%), this reagent was found to be unsuitable for EMSA
experiments. And, while the gel substituted with 50% glycerol was of higher quality, it was still
somewhat ill-defined and fuzzy. A tRNA only control lane was omitted within this reaction set,
and neither assay condition displayed a clear gel shift. However, a greater degree of streaking can
be noted in the first three lanes of each gel where higher concentrations of protein are present. This
streaking is interpreted to represent a LeuRS-I-tRNALeu interaction.
Because gel composition, pore size, and buffering components appeared to have little effect
on the ability to produce a clear shift, we explored the possibility that the majority of the tRNA
substrate was in an inactive conformation. To address this hypothesis, one tRNA pool was folded
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using the typical “slow cool” protocol while a second pool was put through a “snap cool” protocol
where after an initial incubation at temperatures hovering around 90°C, the tRNA was placed
directly in ice. These assays also utilized 5% bis-tris gels (37.5:1) consisting of a 50% glycerol
solution, a consistent quantity of [32P]-tRNALeu-UAG, and varying amounts of LeuRS-I (Figure
8). Again, a clear shift representing a synthetase-tRNA interactions was not observed. However,
as gauged by lanes 1 – 3, the quality of the standard preparation of folding mix appeared to be of
substantially higher quality.
Due to concerns about the quality of the [32P]-tRNALeu-UAG substrate and its advanced
decay, the use of cold tRNALeu-UAG along with an alternative staining method was explored.
SYBR® Gold (Thermo Fisher Scientific) has been shown to be a versatile and highly sensitive
stain for RNA and has already successfully been used in EMSA as reported by Seo and
colleagues.[37] To test its applicability within our system, varying concentrations of cold tRNALeuUAG were folded or left unfolded in the presence and absence of our standard EMSA supplemental
buffer.

The

folding

mixes

were

then

separated

on

a

5%

TBM

gel

(37.5:1

acrylamide:bisacrylamide) and stained with SYBR Gold according to the manufacturer’s
recommendations (Figure 9). As reported, the stain is very sensitive, detecting as little as 17.6 ng
loaded (Figure 9, Lane 1) suggesting that its application in our EMSA assays may prove
beneficial. In addition, this gel shows that, although a tRNA folding protocol is beneficial for
decreasing alternative RNA structures adopted by UAG (Figure 9, arrows) the majority of
“unfolded” tRNA exists in the correct tertiary conformation. Finally, it is clear that the addition of
supplemental buffer to our tRNA folding mixes has no impact on the structure adopted by
tRNALeu-UAG alleviating suspicions of this possibility (Figure 9, compare Lanes 2 and 3 with
Lanes 4 and 5).
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Figure 4. Acrylamide (37.5:1) pore size and its effect on the binding of LeuRS-F to [32P]tRNALeu-UAG. A 5% bis-tris gel with 37.5:1 acrylamide containing a full set of serial diluted
protein from lane 1 – 9, with a final tRNA-only control in lane 10. A total of 50 nM tRNALeuUAG was utilized in addition to each of the protein samples. Lane 1 consists of 1.7 µM final
protein, lane 2 equates to 0.85 µM final protein and subsequent lanes follow 2-fold dilutions. Lane
9 consists of a final protein concentration of 0.0066 µM.
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Figure 5. Acrylamide (29:1) pore size and its effect on the binding of LeuRS-F to [32P]tRNALeu-UAG. A 5% bis-tris gel with 29:1 acrylamide containing a full set of serial diluted
protein from lane 1 – 9, with a final tRNA-only control in lane 10. A total of 50 nM tRNALeuUAG was utilized in addition to each of the protein samples. Lane 1 consists of 1.7 µM final
protein, lane 2 equates to 0.85 µM final protein and subsequent lanes follow 2-fold dilutions. Lane
9 consists of a final protein concentration of 0.0066 µM.
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Figure 6. A 5% bis-tris gel (50% glycerol supplementation) monitoring the binding of
LeuRS-I to [32P]-tRNALeu-UAG. A 5% bis-tris gel with 50% glycerol addition containing a set
of serial diluted protein from lanes 1 – 7. A total of 50 nM of tRNALeu-UAG was utilized in
addition to each of the protein samples. Lane 1 consists of 4.4 µM final protein, lane 2 equates to
2.2 µM final protein and subsequent lanes follow 2-fold dilutions. Lane 7 consists of a final protein
concentration of 0.0335 µM.
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Figure 7. A 5% bis-tris gel (20% TEG) monitoring the binding of LeuRS-I to [32P]-tRNALeuUAG. A 5% bis-tris gel supplemented with 20% TEG containing a set of serial diluted protein
from lane 1 – 7. A total 50 nM of tRNALeu-UAG was utilized in addition to each of the protein
samples. Lane 1 consists of 4.4 µM final protein, lane 2 equates to 2.2 µM final protein and
subsequent lanes follow 2-fold dilutions. Lane 7 consists of a final protein concentration of 0.0335
µM.

47

1

2

4

3

5

6

Figure 8. A 5% bis-tris gel (37.5:1 acrylamide:bisacrylamide) monitoring the binding of
LeuRS-I to [32P]-tRNALeu-UAG folded with variable cooling methods. A 5% bis-tris gel with
variable folding parameters. Lanes 1-3 pertain to the standard folding procedure, while lanes 4 6 correspond to snap-chilled folding mixes. A total 50 nM of tRNALeu-UAG was utilized in
addition to each of the protein samples. Lane 1 consists of 4.4 µM final protein, lane 2 equates to
2.2 µM, and lane 3 equates to 1.1 µM final protein. These concentrations are mirrored for lanes 4
–6
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Figure 9. 5% TBM (37.5:1 acrylamide:bisacrylamide) gel stained with SYBR Gold
monitoring folded and unfolded cold tRNALeu-UAG in the presence and absence of
supplemental buffer. A 5% TBM gel containing different concentrations of cold UAG and varied
incorporation of supplemental buffer. Lane assignments are as follows: 1. 50 nM (17.6 ng) folded
UAG “+” supplemental buffer, 2. 400 nM (141 ng) folded UAG “+” supplemental buffer, 3.
2400 nM (843 ng) folded UAG “+” supplemental buffer, 4. 400 nM (141 ng) folded UAG “–“
supplemental buffer, 5. 2400 nM (843 ng) folded UAG “–“ supplemental buffer, 6. 400 nM (141
ng) unfolded UAG “+” supplemental buffer, 7. 2400 nM (843 ng) unfolded UAG “+”
supplemental buffer, 8. 400 nM (141 ng) unfolded UAG “–“ supplemental buffer, and 9. 2400 nM
(843 ng) unfolded UAG “–“ supplemental buffer. Indication of decreased alternative RNA
structure between folded (white arrows) and unfolded (yellow arrows) tRNALeu-UAG of the same
concentration noted.
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An EMSA assay utilizing LeuRS-I and cold tRNALeu-UAG was performed. Standard
supplemental buffer and folding mix concentrations as noted previously were applied and the
reactions were separated on a 5% TBM gel and stained using SYBR Gold (Figure 10). Following
staining and imaging of the gel, a clear shift was observed even though a corresponding decrease
in the signal of the free tRNA band was not easily recognizable (Figure 10, Lanes 1 – 6). It was
also apparent that the shifted band also approached the well as protein concentration increased
(Figure 10, compare Lanes 1 and 5). Taken together, we suspected that the SYBR Gold stain also
was capable of detecting protein and that the shifted band migrated closer to the wells with
increasing protein as a binding event was occurring (Figure 14, notice slight decrease in free tRNA
from Lanes 4 → 1).
A secondary gel containing only protein was run to discern whether the SYBR Gold was
binding to protein and giving a false impression of a gel shift. Standard reactions were assembled
except excluding the cold tRNALeu-UAG substrate. These reactions were separated on a 5%
(37.5:1 acrylamide:bisacrylamide) TBM gel and stained with SYBR Gold. As can be seen, SYBR
Gold does, indeed, bind to LeuRS-I (Figure 11, arrow) as indicated by a fluorescent band near the
gel wells, primarily in Lanes 1 – 6. Interestingly, although the same concentrations of protein were
used in these tRNA-less EMSA reactions, the staining was largely decreased (compare Figures 10
and 11). In addition, this experiment revealed a suspected problem using EMSA to gauge the
interactions between our LeuRS paralogs with tRNALeu. From Figure 11 it is evident that LeuRSI fails to migrate appreciably into our gels using our gel and buffering system, explaining why
binding has likely been observed with these proteins and tRNA with no discernable gel shift.
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To assess the problem regarding the lack of mobility of both LeuRS-F and LeuRS-I in both
of the tested gel and buffer environments, a 22x20 short plate 8% TBM sequencing gel consisting
of 75:1 acrylamide:bisacrylamide with 0.4 mm spacers was run containing LeuRS-I, LeuRS-F and
E. coli LeuRS (Figure 12). Lanes 1 – 6, which comprised a serial diluted set of LeuRS-F, showed
the most resilience to migration, even under high voltages for long periods of time (8 hours). The
same appeared evident in lanes 7 – 12 which consisted of serial diluted LeuRS-I. E. coli LeuRS
appeared to possess the best ability to migrate within the gel and buffering system tested as evident
from lanes 13 – 18. Interestingly, the rate of migration of each protein perfectly matches
expectations based off their predicted isoelectric points: LeuRS-F, 7.1; LeuRS-I, 5.6; E. coli
LeuRS, 5.2.
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Figure 10. 5% TBM gel stained with SYBR Gold monitoring binding between LeuRS-I and
cold tRNALeu-UAG. A 5% TBM gel (37.5:1 arcylamide:bisacrylamide) consisting of serial
diluted protein and cold UAG folding mix. supplemental buffer consisting of 295 µM MES, pH
6.7, 75 µM ZnSO4 and 20 µM NaCl and a 10x folding mix comprised of 10 µM non-radiolabeled
tRNAleu-UAG (cold UAG), 5 µM MgCl2, 10 µM MES. A total of 50 nM of tRNALeu-UAG was
utilized in addition to each of the protein samples. Lane 1 consists of 4.4 µM protein, lane 2
equates to 2.2 µM and subsequent lanes follow 2-fold dilutions. Lane 9 consists of a final protein
concentration of 0.0085 µM, with lane 10 serving as a tRNA control devoid of protein.
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Figure 11. 5% TBM gel of LeuRS-I, sans tRNA substrate stained with SYBR Gold. A 5%
TBM gel (37.5:1 acrylamide:bisacrylamide) consisting of serial diluted protein devoid of
tRNALeu-UAG. Lane 1 consists of 4.4 µM protein, lane 2 equates to 2.2 µM and subsequent lanes
follow 2-fold dilutions. Lane 10 consists of a final protein concentration of 0.00425 µM.
Indication of stained protein at the eminence of the well is indicated (arrow).
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Figure 12. An 8% TBM 75:1 acrylamide:bisacrylamide native PAGE sequencing gel
containing serial diluted LeuRS-F, LeuRS-I, and E. coli LeuRS. An 8% TBM 75:1 sequencing
gel (dimensions 22x20) of LeuRS-F, LeuRS-I and E. coli LeuRS (left to right). The gel was run
at 800 V for 8 hours in a cold room to reduce heat. Lanes 1 – 6 consist of high concentration
LeuRS-F at an undiluted concentration of 82.7 µM total load, with subsequent lanes being diluted
2-fold. Lanes 7 – 12 portray LeuRS-I at an undiluted concentration of 22 µM total load, with
following lanes diluted 2-fold sequentially. Lanes 13 – 18 consist of E. coli LeuRS at an initial
undiluted concentration of 52 µM total load, with subsequent lanes diluted 2-fold.
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Microscale thermophoresis
Because EMSAs were clearly not an optimal technique for gauging interactions between
S. islandicus LeuRS paralogs and their tRNA substrates, we shifted our attention to microscale
thermophoresis. This process typically monitors the movement of molecules within temperature
gradients and can determine the binding interaction between a set of molecules.[51] Due to the
intrinsic fluorescent characteristics of both LeuRS-F and LeuRS-I decreasing when titrated with
higher tRNA substrate concentrations, standard microscale thermophoresis was deemed as
impossible and, therefore, a secondary method for detecting binding was required. As a workaround to this issue, it was deemed that fluorescence quenching of tryptophan residues on the
proteins could be used to gauge the binding interaction of the protein to tRNA substrate. Binding
reactions were made using 15mM MgCl2, 10 µM ZnSO4, 25mM NaCl, 2mM DTT, 12.5%
glycerol, 60mM MES (pH 6.5), 0.1% pluronic F-127, in vitro transcribed tRNALeu-UAG, and
500nM LeuRS-F or LeuRS-I, along with a gradient of tRNA concentrations from 75 µM to 0.59
µM. The tryptophan residues present on LeuRS-F and LeuRS-I are provided: [LeuRS-F = 19;
LeuRS-I = 11]. Fluorescence quenching results indicated that, shockingly, both LeuRS-F and
LeuRS-I bind tRNALeu-UAG with near-equal affinities (Figure 13). Binding affinities of the
proteins to tRNALeu-UAG reported as µM values in Figure 13. While we were happy to see such
high binding affinities of the proteins to the tRNALeu-UAG substrate, these values are likely
inflated by a magnitude which could either be resultant of the technique of fluorescence
quenching of tryptophan residues or the artificially high tRNA concentrations used within the
experiment. EMSA assays suggest that binding affinities should be around 5 – 10 µM.
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LeuRS-F

LeuRS-I

Leu

tRNA

-UAG KD (µM)

LeuRS-F

27.1 ± 5.8

LeuRS-I

31.4 ± 2.5

Figure 13. Fluorescence quenching of tryptophan residues through protein-tRNA
interaction. Fluorescence quenching was utilized to determine the binding activity between both
LeuRS-F and LeuRS-I with tRNALeu-UAG substrate. Reactions were proceeded with at room
temperature, pH 6.5 and contained 500 nM of each protein. Folded tRNALeu-UAG was added
across three orders of magnitude from 75 µM to 0.59 µM. Scans of fluorescence were fitted in the
Hill equation to assess binding affinities. LeuRS-I (bold lines) and LeuRS-F (grayed lines)
maintain similar binding affinities with tRNA substrate, with calculated binding affinities of
LeuRS-F and LeuRS-I presented in µM values
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tRNA Extraction
The extraction of endogenous tRNA from S. islandicus is of great importance in potentially
determining the activity of LeuRS-I within aminoacylation reactions. The possibility exists that
LeuRS-I does not only bind tRNALeu but also has the capacity to bind non-cognate tRNA’s and
charge them with leucine. While initial aminoacylation reactions with LeuRS-I utilizing in vitro
transcribed tRNALeu have yet to show positive activity, a pool of total tRNA with posttranscriptional modifications could alleviate this problem by offering a wide range of unique
substrate for potential charging. Initial separation of tRNA from S. islandicus wild type strain was
attempted using a generic lithium chloride extraction protocol provided by M.E. Saks, Senior
Research Scientist of biochemistry at University of Illinois Urbana-Champaign. Extractions
utilizing the basic LiCl protocol yielded moderate amounts of nucleic acid substrate as noted by
nanodrop analysis (sample Si wild type total tRNA-1; 10,617 ng/µL, Table A-1), but ultimately
did not yield sufficient quantities of total tRNA for aminoacylation reactions as assessed by
polyacrylamide sequencing gel analysis (Figure 14). Control samples of in vitro transcribed
tRNALeu-UAG were used as an indicator of relative size equal to that of the potential pool of total
tRNA extracted from wild type cells, of which appeared minimal in lanes 3 and 4 of the sequencing
gel. Even the vastly more abundant, Type I tRNAs were isolated in rather small yields (arrow,
Figure 14). However, contamination of high molecular weight nucleic acid was clearly present in
these extraction samples and can be visualized near the wells of the sequencing gel within the two
extraction samples, potentially indicating a source for the moderately high concentration of 10,617
ng/µL found via nanodrop analysis.
A secondary 12% sequencing gel was assembled and run with samples of tRNALeu-UAG,
loading both 1 µg and 2 µg quantities, as well as freshly extracted E. coli tRNA (2 µg) and Si total
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tRNA-1 (2 µg) (Figure 15). The E. coli total tRNA extraction yielded the expected total pool of
tRNA at around ~88 nt of size which correlated to roughly the same size as the in vitro transcribed
tRNALeu-UAG, though contaminating bands of higher molecular weight were also present within
this sample. Si total tRNA-1 still showed a lack of tRNA, and a secondary extraction of wild type
S. islandicus cells was required.
A secondary extraction of S. islandicus wild type cells was performed using an increased
volume of cells grown at 75°C. Si total tRNA-2 was run in tandem with E. coli total tRNA as a
comparative sample on a 2% agarose bleach gel. From this gel as well as the NanoDrop analysis
(sample Si total tRNA-2; 20,081 ng/µL, Table A-1), it is clear that when using smaller volumes
of the initial LiCl and phenol:chloroform:isoamyl alcohol reagents, extractions yielded greater
quantities of total tRNA at a superior quality (Figure 16).
Higher molecular weight nucleic acid species were also present in the Si total tRNA-2
sample, which was a trend seen within every extraction performed. These contaminating nucleic
acid species required removal for downstream applications such as aminoacylation where knowing
the actual tRNA concentration is crucial. E. coli total tRNA was utilized as a substrate to test a
new chemical extraction method for removing these unwanted contaminants. Utilizing raw LiCl
reagent and subsequent ethanol cleanup, E. coli total tRNA was fractionated from large
contaminating nucleic acids (Figure 17).
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88 nt
Type I tRNA’s

Figure 14. 12% sequencing gel analysis of Si wild type total tRNA and
tRNALeu-UAG. Gel was run maintaining an approximate 1250 V and stained
using Stains-All. Lane assignments are as follows: 1. 1 µg Si tRNA-1, 2. 2 µg of
Si tRNA-1, 3. 1µg tRNALeu-UAG, and 4. 2 µg of tRNALeu-UAG. Isolated Type I
tRNAs are indicated (arrow).
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Figure 15. 12% sequencing gel analysis of Si wild type total tRNA and E. coli total tRNA.
Gel was run maintaining an approximate 1250 V and stained using Stains-All. Lane assignments
are as follows: 1µg and 2µg of tRNAleu-UAG (lanes 1 & 2 respectively) along with 2µg of E. coli
total tRNA (lane 3) and Si total tRNA-1 (lane 4). Relative size of tRNALeu-UAG at 88 nt aligns
with total tRNA sample found within E. coli total tRNA. Isolated Type I & II tRNA as well as 5S
rRNA or mRNA are indicated (arrows).
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Figure 16. 2% agarose bleach gel of E. coli total tRNA and Si total tRNA. Agarose bleach gel
run in 1x TAE buffer at a constant 90 mA for 30 minutes. Staining achieved by the addition of
0.5 µg/mL ethidium bromide. Lane assignments are as follows 1. Low range ssRNA ladder, 2. 2
µg E. coli total tRNA, 3. 2 µg Si total tRNA-2. Arrow indicates pool of total tRNA at around
roughly 80 nt in size. Ladder is marked with weights of upper bands.
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Figure 17. Fractionation of total E. coli tRNA from high molecular weight nucleic acids
Agarose bleach gel run in 1x TAE buffer at a constant 90 mA for 30 minutes. Staining achieved
by the addition of 0.5 µg/mL ethidium bromide. Lane assignments are as follows: 1. Low range
ssRNA ladder, 2. 2µg unprocessed E. coli total tRNA, 3. 2µg contaminant-extracted E. coli total
tRNA. Size indication of the total pool of tRNA shown (arrow) as well as the top band sizes of
the low range ssRNA ladder.
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Initial fractionation of E. coli total tRNA from high molecular weight nucleic acids was a
reassuring move in the right direction, though a larger molecular weight band was still present in
the extracted sample. As larger RNA species are insoluble in LiCl[47], we assumed that the initial
fractionation removed mRNA and 5S ribosomal RNA leaving behind genomic DNA within the
tRNA sample. Therefore, a small amount of Si total tRNA-2 was subsequently processed with
DNase in an attempt to remove the high molecular weight band. As can be seen from Figure 18,
an overnight digest at 37°C using 2 units of DNase effectively removed this contaminating species,
confirming our suspensions. Importantly, these additional, straightforward procedural steps are
highly effective at cleaning and enriching our RNA pool for total tRNA.
These additional steps were applied to the crude Si total tRNA-2 pool. A bleach agarose
gel (Figure 19) tracking the full process of contamination cleanup was run. As can be seen in lane
3 of the gel, a high-fidelity digestion of DNA was achieved by the addition of 2 units of DNase to
the sample. A LiCl extraction of the remaining contaminating bands was attempted, but ultimately
failed due to the improper addition of absolute ethanol during the extraction procedure (Figure 19,
Lane 4) which ultimately precipitated both large and small RNAs. To remedy this, a secondary
extraction using only LiCl reagent was performed, afterwhich much of the contaminating nucleic
acids were removed from the pool of total tRNA (Figure 19, Lane 5).
A secondary extraction of crude Si total tRNA was carried out at the stressful condition of
60°C to provide a secondary substrate for potentially eliciting activity within aminoacylation
reactions involving LeuRS-I. This temperature was chosen for growth due to possible differences
in the modification types present on the tRNA’s at sub-optimal temperatures of growth, as noted
by McCloskey and cohort within the hyperthermophilic Methanococcales.[48] These potential
differences in modification could be required for activity elicitation with LeuRS-I in
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aminoacylation reactions. Along with this, it is possible that LeuRS-I works with non-cognate
tRNA as is seen in mammalian systems with MetRS,[22] providing further importance to
performing low-temperature extractions. Utilizing the aforementioned processes of extraction and
contaminant removal, this secondary extraction yielded high concentrations of relatively pure
substrate (Table A-1 & A-2) as shown in initial extraction samples Si total tRNA-3 (11,080 ng/µL)
and Si total tRNA-4 (14,050 ng/µL), as well as the purified and pooled Si total tRNA (60°C) at
14,280 ng/µL. Figure 20 is a bleach agarose gel tracking the aforementioned samples.
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Figure 18. 2% agarose bleach gel tracking the digestion of Si total tRNA-2 with DNase.
Agarose bleach gel run in 1x TAE buffer at a constant 90 mA for 30 minutes. Staining achieved
by the addition of 0.5 µg/mL ethidium bromide. Lane assignments are as follows: 1. Low range
ssRNA ladder, 2. Undigested Si total tRNA-2 at ~1.5µg, 3. DNase digested Si total tRNA-2 at
~0.8µg. Successful digestion of DNA is apparent from the loss of signal indicated at the top
of the gel (arrow). Ladder assignments in nucleotide are displayed for the top two bands.
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Figure 19. 2% agarose bleach gel tracking contamination cleanup in Si total tRNA-2.
Agarose bleach gel run in 1x TAE buffer at a constant 90 mA for 30 minutes. Staining achieved
by the addition of 0.5 µg/mL ethidium bromide. Lane assignments are as follows: 1. Low range
ssRNA ladder, 2. unprocessed extracted Si total tRNA-2, 3. DNase digested Si total tRNA-2, 4.
Failed LiCl extraction Si total tRNA-2, 5. Final processed Si total tRNA-2. All samples were
standardized to 1 µg of total loaded nucleic acid.
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Figure 20. 2% agarose bleach gel depicting Si total tRNA-4 & 5 and final processed and
pooled low temperature total tRNA. Agarose bleach gel run in 1x TAE buffer at a constant 90
mA for 30 minutes. Staining achieved by the addition of 0.5 µg/mL ethidium bromide. Lane
assignments are as follows: 1. Low range ssRNA ladder, 2. Si total tRNA-4, 3. Si total tRNA-5,
4. Purified low temperature total tRNA. Total pool of tRNA indicated at roughly 80 nucleotides
(arrow) along with the sizes top bands of low range ssRNA.
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LeuRS-I C-terminal domain expression and purification
In an effort to understand the activity of LeuRS-I, tools for determining the expression
levels of the protein in vivo are required. In order to do this, two distinct avenues for obtaining this
result were taken – the development of custom polyclonal antibodies raised against the C-terminal
domain of LeuRS-I that are specific in their recognition of LeuRS-I but not LeuRS-F, and the
generation of a wild type S. islandicus strain harboring a fusion tagged LeuRS-I protein. Both of
these methods will allow us to determine both when and at what levels LeuRS-I is expressed and
if this expression is modulated via stressful environmental conditions. These generation of
selective antibodies also has the added benefit of determining whether LeuRS-I has a unique
binding partner with which it makes interactions, such as LeuRS-F or another endogenous protein.
For the development of polyclonal antibodies, it was determined that the C-terminal domain of
LeuRS-I was the best candidate to raise the antibodies against due to this portion of the protein
being most dissimilar to LeuRS-F (Figure 21).
This fragment containing ~20% sequence identity to LeuRS-F was cloned into pET14b (+)
(Novagen) and used to transform BL21(DE3) (NEB). It is important to note that both enzymes
share a small block of amino acids that are very similar at the C-termini of each protein. The
expression and affinity purification of the C-terminal domain (CTD) of LeuRS-I [His6-LeuRS-I
(789-934)] was monitored via SDS-PAGE. After lysis via sonication, soluble lysates (Figure 22,
Lane 3) were loaded onto columns containing Ni2+-NTA resin which captures the His-tag fused to
the N-terminus of the LeuRS-I CTD. Following several rinse steps (Figure 22, Lanes 5 – 8), the
bound protein was eluted with a large volume of high concentration buffered imidazole leading to
a seemingly low protein yield (Figure 22, Lane 9). The eluted protein was dialyzed and
concentrated into a buffer suitable for thrombin digest, the aim of which is to remove the His-tag
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from His6-LeuRS-I(789-934) (Figure 22, Lane 10, 19.2 kDa, circled). As gauged from the gel, a
moderate amount of the desired protein was acquired, and approximately 60% pure (Figure 22,
compare Lanes 3 and 10). Following the purification of the C-terminal domain, the total protein
concentration was determined to 7.52mg.
To remove the His-tag and generate a LeuRS-I CTD better approximating the wild type
sequence, a thrombin digest was performed. Initial trials tested several molar ratios of
thrombin:His6-LeuRS-I(789-934) over the course of 24 hours (data not shown). A large-scale
digest was carried out and monitored via SDS-PAGE over the course of sixteen hours (Figure 23).
While the thrombin digest was complete after 2 hours (Figure 23, compare arrows in Lanes 2 and
3), the cleaved protein migrated as a doublet. We speculate that this aberrant migration pattern is
the result of thrombin miscleavage on a portion of the LeuRS-I fragment or that a subset of our
purified protein had become oxidized. Regardless, the predicted molecular weight of our cleaved
protein (17.3 kDa) matches that observed within our SDS-PAGE analysis within the resolution of
the experiment. However, incredibly pure protein is needed to raise a custom antibody and Figure
23 suggested that a secondary column was needed to further purify our cleaved LeuRS-I variant.
Because the thrombin utilized in cleavage reactions was biotinylated it was readily
captured with streptavidin-coated beads (data not shown). Following this step, His-tags liberated
from the cleavage reaction were removed by passing digested and thrombin-removed LeuRS-I
(789-934) over Ni2+-NTA resin (Figure 24). This added step not only removed the unwanted and
freed His-tags, but also removed considerable amounts of additional, contaminating protein
species (Figure 24, compare Lane 1/3 with Lane 4). However, remaining contaminants with
molecular weights hovering around 70 – 75 kDa were still present.
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Figure 21. Sequence alignment between the C-terminal domain of LeuRS-I (residues 789934) and LeuRS-F (residues 789-944). Alignments of the C-terminal domains of each of these
proteins indicative of lowest sequence identity (20%) between the two proteins and was
determined to be the best fit for raising polyclonal antibodies selective in their recognition of
LeuRS-I.
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Figure 22. 15% SDS-PAGE tracking the affinity purification of His6-LeuRS-I (789-934).
Lane assignments are as follows: 1. 250 kDa ladder (Goldbio), 2. sonicated cell mass, 3.
supernatant of cleared lysate, 4. flowthrough, 5. lysis rinse, 6. imidazole rinse 1, 7. imidazole rinse
2, 8. final eluted C-terminal fragment, 9. dialyzed C-terminal fragment. Boxed protein indicated
within the dialyzed fraction is the 19.2 kDa C-terminal fragment.
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Figure 23. 15% SDS-PAGE tracking the thrombin digest of His6-LeuRS-I (789-934). The
digestion of C-terminal protein with thrombin was initiated by the addition of 2 units of thrombin
to the dialyzed C-terminal solution. Lane assignments are as follows: 1. 250 kDa Ladder
(Goldbio), 2. undigested His6-LeuRS-I (789-934), 3. 2-hour digestion of His6-LeuRS-I (789-934),
4. 4-hour digestion of His6-LeuRS-I (789-934), 5. 16-hour digestion of His6-LeuRS-I (789-934).
Cleaved protein exhibits a size of 17.3 kDa and are indicated (arrows)
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Figure 24. 15% SDS-PAGE monitoring the His-tag removal from cleaved LeuRS-I (789934). Liberated His-tags were removed via NTA-Ni2+ resin. Lane assignments are as follows: 1.
digested His6-LeuRS-I (789-934) with contaminants, 2. 250 kD protein ladder (GoldBio), 3.
digested His6-LeuRS-I (789-934) with contaminants (duplicate of lane 1), 4. digested and purified
His6-LeuRS-I (789-934), 5. undigested and dialyzed His6-LeuRS-I(789-934), 6. undigested and
dialyzed His6-LeuRS-I (789-934) (duplicate of lane 5).
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Because of the relatively low isoelectric point of LeuRS-I (789-934) (~ 5 – 6), anion
exchange chromatography utilizing DEAE cellulose resin was used for further purification. The
purification was tracked via 15% SDS-PAGE (Figure 25). After binding under low salt conditions,
a step-wise salt gradient was used to elute LeuRS-I (789-934) from the resin. As can be seen
(Figure 25, Lanes 3 – 8), cleaved LeuRS-I (789-934) elutes from the DEAE resin at a salt
concentration of 75 mM. Interestingly, this ion-exchange chromatography method was effective
at not only separating the cleaved protein from the high molecular weight species, but also from
the second, upper band within the doublet visualized in Figures 23 and 24 (Figure 25, compare
Lanes 6 and 7). The high molecular weight species were eluted at a salt concentration of 150 mM
(Figure 25, Lanes 9 and 10). Fractions 1 – 6, corresponding to lanes 3 – 8, containing the greater
than 98% pure cleaved LeuRS-I (789-934) were pooled, dialyzed into 10 mM Na2HPO4, 2 mM
KH2PO4, 137 mM NaCl, 2.7 mM KCl, 2 mM EDTA, 1 mM DTT, 5% glycerol, pH 7.5,
concentrated to 0.786 mg/mL, and provided to Pierce Custom Antibody Services (Thermo
Scientific, 2.5 mL) to develop a rabbit polyclonal antibody (2 rabbits: AB1806 and AB1807, 72
day protocol).
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Figure 25. 15% SDS-PAGE monitoring the anion exchange purification of cleaved LeuRSI (789-934). The removal of a contaminating protein from the C-terminal domain protein was
facilitated by anion exchange chromatography using DEAE cellulose resin and increasing
concentrations of NaCl (75 mM to 150 mM). Lane assignments are as follows: 1. 250kD ladder
(Goldbio), 2. undigested and dialyzed His6-LeuRS-I (789-934), 3 – 8. purified and digested His6LeuRS-I (789-934), 9 & 10. contaminant protein.
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HA-I plasmid construction
As a secondary approach to gauge in vivo expression levels of LeuRS-I, we aimed to
generate a strain with wild type growth behavior that encoded a genomic HA-tagged LeuRS-I.
This particular design would facilitate experimentation by using a commercially available antibody
that can detect the HA epitope. The construction of a HA-tag/LeuRS-I fusion on the chromosome
of S. islandicus M.16.4 was carried out utilizing a previously developed pRJW08 suicide vector.[11]
To begin, the assemblage of components integral to the formation of this LeuRS-I construct was
performed using a Gibson assembly methodology to link a pre-constructed gene fragment (gBlock)
constituting a 730 3’ segment of the LeuRS-I gene (Tg) fused to the sequence for the HA tag and
a 868 bp downstream fragment (D1, IDT), with pRJW08 (Figure 26, plasmid map).[52] Following
the assembly of the gBlock fragment into pRJW08 and transformation, resulting colonies from
both room temperature and 37°C plates were screened to identify clones with the successfully
generated recombinant plasmid. Two clones from both temperatures were identified and the
colonies from which were miniprepped and screened for the gBlock fragment (Figure 27).
Following a secondary screen of these intermediary plasmids to ensure their integrity
through culturing and isolation from E. coli, a second DNA fragment (D2) identical in every way
to D1 except its location within pRJW08 was generated via PCR and ligated into pRJW08gBlock(+) (see Figure 26, plasmid map). This second downstream gDNA fragment is required
for the proper integration and subsequent removal of plasmid-borne genes to and from S. islandicus
(Figure 27). Colony screening of competent cells transformed with this ligated plasmid were
screened via PCR and a positive integrant was found (Figure 27, blue block). Cells harboring this
D2 positive vector were carried forward and re-screened for the gBlock fragment to ensure that
the proper elements were unfettered following ligation and transformation of the D2 fragment

75

(Figure 28). Figure 29 details the important elements integrated into the pRJW08 vector in
addition to the markers needed to facilitate the introduction of the HA-tag onto the C-terminus of
LeuRS-I.
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arm (D1), black; Down-2 arm (D2), black – opposite D1. These DNA fragments are required for
recombination and folding out (or, exclusion) of unnecessary plasmid-borne elements following
isolation and counterselection of integrant-positive cells.
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Figure 27. 1.5% agarose gel depicting the introduction of the D2 fragment into pRJW08gBlock(+). The previously assembled pRJW08-gBlock(+) vector was ligated with a secondary
fragment, D2, and was transformed into competent cells. Screening of these colonies for the D2
fragment was performed using primer pair M87 and FOR88. Lane 12 indicates a positive screen
of the D2 fragment (circled, blue), 867 bp in size.
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Figure 28. 1.0% agarose gel depicting the introduction of the D2 and gBlock fragment
within discrete minipreps of the positive pRJW08-gBlock/D2(+) vector (HA-I). The
positively screened HA-I vector was miniprepped in three distinct elution’s and screened for each
introduced element (gBlock and D2). Screening of these plasmid preps for the D2 fragment was
performed using primer pair M87 and FOR88, as shown in lanes 2, 4, and 6. Lanes 3, 5 and 7
indicate screening of the gBlock fragment with primer pair M9 and REV99. Expected sizes for
the D2 and gBlock fragments were 867 bp and 1598 bp, respectively
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Transformation of S. islandicus wild type with the HA-I vector
Following the successful construction and sequence verification of the HA-I construct, it
was linearized and used to transform our working S. islandicus wild-type strain. Integration of the
linearized plasmid into S. islandicus’ genome and the subsequent removal of unnecessary plasmidborne components operates under the principle of modified Marker Insertion and unmarked gene
Deletion (MID) methodology.[53] Following the insertion of the plasmid at the genomic target locus
of LeuRS-I and the upstream nucleoside hydrolase, 5-FOA counterselection invokes the “popping
out” of extraneous genetic material[54], namely by random genomic dynamics allowing both the
D1 and D2 fragments to overlap and extrude out the selectable marker system first introduced with
the plasmid as a circular suicide vector. Various amounts of the linearized vector were used for
these experiments, ranging from 0.5 μg to 1.5 μg. Both 1.0 μg and 1.5 μg of vector yielded a
number of colonies ideally representing clones with the vector inserted after the 3’ end of the gene
coding for LeuRS-I (Figure 29). X-gal staining of colonies harvested from both of these plates
indicated a strong blue hue showing proper introduction of the linearized HA-I vector into its
genomic destination in selected strains 1 µg P1 (Pick 1), 1 µg P5, 1.5 µg P2 and 1.5 µg P4 isolates
(Figure 30). X-gal positive strains were colony purified, and these strains maintained blue staining
in the presence of this lactose analog (data not shown). Counterselections to remove the
unnecessary plasmid-borne components, but maintain the HA C-terminal fusion of LeuRS-I
(Figure 31), resulted in the removal of the lacS gene, an ortholog of beta-galactosidase that elicits
the metabolism of lactose and, therefore, the indicative presence of blue within the sample.
Therefore, counterselected strains did not produce blue pigment upon exposure to X-gal, indicating
the removal of these extraneous genes (lacS, pyrEF, argD) from the genome of these fusion strains.
Following counterselection, the transformants were screened using an HA specific primer to
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elucidate the presence of this genomically located epitope tag (Figure 31). Moreover, clones were
further verified using Sanger sequencing at the Core DNA Facilities at UIUC.

Figure 29. Modified MID recombination scheme for introduction of a C-terminal HA tagged
fusion with leuRS-I. Recombination scheme depicting linearized PRJW08 and its insertion into
S. islandicus’ genome as well as the removal of extraneous genetic elements from S.i wild type’s
genome using a modified MID methodology. Overlapping of the D1 and D2 fragments, which are
identical sequences, during 5-FOA counterselection causes the selection cassette comprised of
lacS, pyrEF, and argD to be extruded, leaving behind a genomically HA tagged variant of LeuRSI.
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Figure 30. X-gal staining of S. islandicus with integrated HA-I. Following the transformation
if S. islandicus with the HA-I vector, colonies were harvested and grown in DT medium then
subsequently stained with X-gal. Microfuge tubes 1 and 2 indicate colonies derived from the 1 µg
transformation plates, samples 1µg P1 and 1µg P5, respectively. Microfuge tubes 3 and 4 relate
to colonies derived from the 1.5 µg transformation plate, samples 1.5µg P2 and 1.5µg P4,
respectively. This selection of cultures is not indicative of the total set of transformants that
screened positive with X-gal, but are a select few that indicated blue pigment production.
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Figure 31. 2% agarose gel depicting screens of the genomically integrated HA tag in S.
islandicus M.16.4. Purified and counterselected strains were screened using primer pair LRSI
1724 and M97, the latter being a primer that binds specifically to the HA tag. Lane assignments
are as follows: 1. 100bp ladder (Goldbio), 2. Sample 1 µg P1, 3. Sample 1 µg P2, 4. Sample 1µg
P3, 5. Sample 1µg P5. Positive screens indicate a band slightly above the 1000bp band on the
ladder. Expected band size: 1042 bp
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Growth curve of the HA-I strain with S. islandicus wild type strain
The ability to utilize the newly generated HA-I strain in expression profiling was
predicated on its ability to possess a phenotype close in nature to wild type S. islandicus cells. If
the strain were to behave in a strange manner as compared to wild type S. islandicus, it would
render any results obtained from expression profiling as confounded and dubious given the
possibility of the HA tag impacting the activity of LeuRS-I or of errant genetic abnormalities
incurred during the development of the HA-I strain. The stressful temperature of 60°C was
employed to exacerbate any phenotypic differences from the HA-I strain in comparison to S.
islandicus wild type. Growth curve data indicated a strong tracking of optical densities between
the triplicates employed within the experiment with little deviation of note (Figure 32).
Maximum optical densities achieved were 0.532 and 0.528 for S. islandicus wild type and the
HA-I strain, respectively, with a death phase concurrent between the two strains on day 8 of the
growth curve.
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S. islandicus HA-I vs WT growth curve @ 60°C
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Figure 32. Growth curve data of S. islandicus wild type strain and the HA-I strain. O.D600nm
values were gathered at the same time of each day in 24 hour increments over the course of 9
days. Data represents triplicate averaging between the two strains. Error bars are present but are
nearly indistinguishable at each data point due to the tight tracking of optical density between
the two strains
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Expression profiling of the HA-I strain
In an attempt to better understand the in vivo expression of LeuRS-I within S. islandicus
and assess whether such expression could be modulated with the introduction of stressful growth
temperatures, an expression profiling experiment was performed using the HA-I strain and FLAGF strain. Following the assessment of the HA-I strain within a growth curve, it was determined that
the strain was suitable for expression profiling via western blot analysis. Cultures grown at 75°C
and 60°C were harvested at variable optical densities equating to low (LOD), mid (MOD) and high
(HOD) optical densities to assess any possible temporal expression or modulation within given
stages of growth under the two conditions. Due to a loss of roughly half of the volume in one of
the HA-I flasks at 60°C, lysis conditions were halved accordingly. Following the lysis and
quantitation of protein from each sample, SDS-PAGE was run following the standardization to 1.5
µg total loaded protein within each sample. Western blot analysis indicated the presence of HA-I
within all collected samples at both growth temperatures on x-ray film (Figure 33). Densitometry
assessment revealed interesting patterns of expression of LeuRS-I in vivo, with a clear indication
of importance of the enzyme at low optical densities within both the standard and low temperature
growth cultures (Figure 34). A steep decline in the expression of LeuRS-I at 60°C as compared to
the relatively maintained expression of the protein during MOD at 75°C was noted, though the
implication of such data is unclear at this moment. The expression of LeuRS-I at HOD appears
reduced in both the 60°C and 75°C samples, which could be an artifact of cells harvested at these
high optical densities being at or close to their death phase, or because the expression of LeuRS-I
is downregulated at such high optical densities. Densitometric data was generated using FIJI. The
FLAG-F strain did not show any signal when probing via western blot, so it has been excluded
from any densitometric testing.
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Figure 33. X-ray film depicting the expression of HA-I across differential temperatures and
optical densities. Western blot analysis performed on the HA-I strain at the temperatures of 60°C
and 75°C at low (LOD), mid (MOD), and high (HOD) optical densities. The blot was developed
using a calculated 1.5 µg of total protein within each lane of an 8% stacking, 10% resolving
SDS-PAGE. Order of samples is as follows: 1. 60°C HA-I (LOD), 2. 75°C HA-I (LOD), 3. 60°C
HA-I (MOD), 4. 75°C HA-I (MOD), 5. 60°C HA-I (HOD), 6. 75°C HA-I (HOD)
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LeuRS-I expression at standard and sub-standard
temperatures
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Figure 34. Densitometric intensity counts of LeuRS-I expression at 75°C and 60°C. FIJI was
utilized to develop standardized densitometric counts of in vivo LeuRS-I expression via
histogram area analysis. Background subtraction was performed using blank X-ray film and
subtracting the given counts from all sample densitometric readings. Expression is portrayed as
arbitrary units of densitometric intensity.
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CHAPTER IV: CONCLUSION
As presented, a variety of angles have been probed in an attempt understand the
functional relevance of LeuRS-I in Sulfolobus islandicus. While this question is left unanswered
in full, a few key insights have been made that act as steppingstones towards potentially fruitful
experimentation that could ultimately answer this unknown. Given LeuRS-I’s lack of activity
within aminoacylation reactions, it is indeed a startling discovery that not only does LeuRS-I
bind in vitro transcribed tRNALeu-UAG, but it does so at roughly the same binding affinity as
LeuRS-F. This brings into light a possibility in which LeuRS-I either requires a specifically
modified version of tRNA in which to impose its aminoacylating properties upon, or it requires
accessory proteins to elicit aminoacylation. With the use of the custom developed polyclonal
antibody, purifying LeuRS-I and potential accessory proteins out of wild type S. islandicus is
possible, making the latter possibility testable.
And yet, preliminary aminoacylation reactions with LeuRS-I utilizing endogenously
extracted and post-transcriptionally modified tRNA’s appear negative for aminoacylation
activity, bringing into question its role as a canonical synthetase. The potential exists in which
LeuRS-I has maintained its ability to bind tRNA due to its core aesthetic of being an aminoacyltRNA synthetase, but has been evolved over an ancient timescale to perform an exotic secondary
function such as charging amino acids on to proteins to modify their chemical properties or
generating small molecules of utility to S. islandicus. Such possibilities could be tested using
modified aminoacylation reactions that track the attachment of amino acids onto alternative
proteins or by utilizing mass spectrometry to identify substitutions of amino acids on these
proteins.

88

Phylogenetic analysis of the LeuRS enzymes within the Sulfolobaceae has provided a
strong argument for this paralog’s maintenance within every member of the family, including
strains separated by geographical barriers of thousands of miles. Due to the omnipresence of
LeuRS-I within these organisms, it is not difficult to imagine that this paralog exhibits a strong
functional relevance to the species, though it is ultimately unknown what this importance is.
Analysis of LeuRS-I’s expression in response to sub-standard growth temperatures was a good
starting point for determining if this paralog’s expression can be modulated by abiotic stress, but
a host of other experiments can be utilized in an attempt to exacerbate this modulation including
differential environmental pH’s and oxidative stress experiments. Indeed, further use of the
molecular tools generated within this thesis could help untangle the mystery behind the activity
of this unique paralog within S. islandicus.
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APPENDIX A: TABLES
Sample

Volume

Concentration

(µL)

(ng/µL)

10

E. coli total tRNA (37°C)

Si wild type total tRNA-2

Si wild type total tRNA-1

A260/280

A260/230

10,617

2.13

1.54

100

6,491

2.11

1.34

50

20,081

2.10

2.10

50

11,080

2.11

2.00

50

14,050

2.10

2.16

(75°C)

(75°C)

Si wild-type total tRNA-3
(60ׄ°C)

Si wild-type total tRNA-4
(60ׄ°C)

Table A-1: Concentrations of total tRNA preps, unprocessed samples. Total tRNA preps from
extracted S. islandicus or E. coli cells, unprocessed.

98

Sample

Si wild type total tRNA-2(5)

Volume

Concentration

A260/280

A260/230

(µL)

(ng/µL)

40

12,858

2.04

2.10

~75

14,280

1.98

1.88

(75°C)

Si wild-type total tRNA
(pooled) (60ׄ°C)

Tables A-2: Concentrations of total tRNA preps (purified). Concentrations and quality
assessments of processed and cleaned total tRNA pools from contaminating nucleic acids.
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Primer name
Application
M9
pRJW08+gBlock
Rev99
pRJW08+gBlock
M57
Downstream 2 (D2) fragment amplification
M58
Downstream 2 (D2) fragment amplification
M97
HA-tag screening, LeuRS-I
LRSI 1724
HA-tag screening, LeuRS-I
Table A-3: Primers used in this study. All primers that were used in screening or generation of
plasmids are listed.
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